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ABSTRACT 
 
 
Jill Kristin Center 
 
Applying the Public Health Code of Ethics to the Federal Workforce 
 (Under the direction of Edward Brooks, DrPH) 
 
 
Although the public health code of ethics was published in 2002, it has not been widely 
disseminated or formally adopted by the two largest public health institutions within the U.S. 
Public Health Service —the Centers for Disease Control and Prevention (CDC) and the 
National Institutes of Health (NIH).  In order to determine the applicability and feasibility of 
implementing the public health code of ethics within the federal government, this study 
examines the ethics programs in the two largest public health agencies; how the current 
ethics programs at these agencies compare with the principles in the public health code of 
ethics; and where benefits to adopting the code are identified, how barriers to implementing 
it can be addressed. 
 
Results from this study revealed that both agencies are addressing most of the principles in 
the code of ethics with their current practices, policies, and ethics activities.  CDC officials 
interviewed for this study had a high degree of familiarity with the code and indicated that it 
is an integral part of the agency’s public health ethics program.  The code of ethics is a tool 
that aligns with the CDC’s mission and is well-suited for formal adoption by the agency.  The 
NIH has an ethics program that is appropriately geared toward research ethics.  While there 
would be little benefit from NIH adopting the public health code of ethics agency-wide, NIH 
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should consider the code for the segment of its workforce that designs, manages, and 
evaluates public health education, campaigns, and research programs.  In addition, the 
Public Health Leadership Society should clarify the rationale for the public health code of 
ethics, thereby extending its reach. 
 
 
There is a role for the public health code of ethics in the federal workforce.  The CDC should 
adopt the code for use agency-wide and the NIH should use the code with the segment of 
its employees doing direct public health outreach and research in communities.  In addition, 
the Public Health Leadership Society should take a more active role in articulating the need 
for the code and engage in activities that will facilitate wider awareness and use of it.  
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CHAPTER 1: INTRODUCTION 
Leaders in public health have undertaken an effort to further “professionalize” the field in several 
ways.   This movement has included activities such as identifying and promoting a common set 
of competencies for the public health workforce, marketing a national credentialing examination 
to test for mastery of several core competencies, proposing that public health professionals be 
certified to engage in certain core activities, and establishing common principles of the ethical 
practice of public health, referred to in this study as the “public health code of ethics.”  The 
public health code of ethics was published in 2002, but has not been widely disseminated or 
formally adopted by the largest public health institutions—the U.S. federal agencies with public 
health missions.  A large segment of the public health workforce is employed or funded by the 
federal agencies that comprise the U.S Public Health Service (PHS).  Employees in the PHS 
agencies are subject to a legislated code of ethical behavior which applies to all employees of the 
Executive Branch of the federal government.  In order to determine the applicability and 
feasibility of implementing the public health code of ethics within PHS agencies—and in 
particular the two largest agencies within the PHS—it is important to consider three key 
questions:  
1. In the context of the 12 principles of the public health code of ethics, what are the 
current practices of the National Institutes of Health and the Centers for Disease 
Control and Prevention, the two largest federal public health agencies?   This will 
include identification of the areas that are currently well-covered as well as the gaps.  It 
will also define what additional benefit the code of ethics can provide, over and above the 
current mandated ethical standards. 
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2. To what extent has the public health code of ethics been given specific consideration 
by the two largest federal public health institutions?  This will include an exploration 
of why the code of ethics has not been adopted by the agencies as well as any perceived 
barriers to doing so. 
3. If benefits are identified, how can specific barriers to implementing the code of 
ethics be addressed to fill gaps in the agencies’ current ethics programs? 
 
United States Public Health Service Agencies 
The United States Department of Health and Human 
Services (HHS) is the federal entity charged with 
protecting the health of Americans and providing 
essential human services.  This Executive Branch 
department is comprised of eleven divisions which carry 
out activities in the areas of health and human services.  
Eight of the divisions combine to form the U.S. Public 
Health Service (PHS) and represent the majority of the 
U.S. government’s investment in health research, 
services, funding, and support.  The PHS has a workforce 
of approximately 56,000 people across the country and a 
combined annual budget of approximately $52 billion.1 
Employees within the PHS must conduct their work 
according to the standards of ethical conduct mandated for Executive Branch employees.2   
                                                           
1 Analysis of data from United States Public Health Service, Department of Health and Human Services. 
2 The Standards of Ethical Conduct for Employees of the Executive Branch is mandated under 5 C.F.R., Part 2635. 
 
Figure 1: United States Public 
Health Service Agencies 
Agency for Health Care and 
Research Policy   
Agency for Toxic Substances 
and Disease Registry   
Centers for Disease Control and 
Prevention   
Food and Drug Administration  
Health Resources and Services 
Administration   
Indian Health Service  
National Institutes of Health  
Substance Abuse and Mental 
Health Services Administration 
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While the PHS includes a total of eight agencies which conduct some public health-related work, 
the scope of this study includes the two largest agencies within the PHS: the National Institutes 
of Health (NIH) and the Centers for Disease Control and Prevention (CDC).  These agencies 
employ or fund the majority of the federal public health workforce and represent the greatest 
federal financial investment in public health research and programs.  The NIH had an annual 
budget of $29 billion in fiscal year 2008 and a workforce of over 18,000 people, and CDC, 
whose budget in fiscal year 2008 was $6.4 billion, employs approximately 15,000 staff and 
contractors.  Outside the scope of this study are other offices and agencies within HHS with 
public health-related missions— such as the Office of Public Health Preparedness and the Office 
of the Surgeon General.  While the NIH and CDC do not represent the universe of federal public 
health workers, they are major employers of the public health workforce and also have a role in 
providing funding and support to the states and to academic communities for public health 
activities and research.  If the field of public health is moving to establish a common code of 
ethics, it should fill gaps in current practices and be compatible with the ethical standards 
legislated for federal employees in the Executive Branch, such as those within the NIH and 
CDC.   
The Public Health Code of Ethics  
In 2002, the Public Health Leadership Society published the Principles of the Ethical Practice of 
Public Health, which includes twelve principles that make up the public health code of ethics 
(see Figure 2) and a set of eleven values and beliefs that underlie the code (Public Health 
Leadership Society, 2002).  The Public Health Leadership Society later developed a companion 
piece entitled Skills for the Ethical Practice of Public Health which provides guidance on 
moving the public health code of ethics into practice (Thomas, 2004).  The work to develop the 
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public health code of ethics was funded in part by the CDC.  The code was adopted by the 
American Public Health Association (APHA) in 2002 and has been endorsed by several public 
health organizations.  
There are two features of the public health code of ethics that hint at its potential to be used in 
conjunction with the mandated standards, both of which are described by Dr. James Thomas, an 
author of the code of ethics, in his on-line lecture and learning modules on public health ethics 
(Thomas, accessed October, 2007 and October, 2010)(Thomas, accessed October, 2007 and 
October, 2010).  First, the code of ethics was written with a focus on public health agencies 
rather than on individuals, a focus that parallels the emphasis of public health on the health and 
well being of populations rather than individuals.  It was designed to be adopted by institutions 
to provide guidance for the ethical practice of public health.  Second, Thomas describes the 
public health code of ethics as being “aspirational”—articulating a set of broad standards to 
which the field should aspire.  In contrast, the Standards of Ethical Conduct for Employees of the 
Executive Branch which governs federal employees is a “prescriptive” set of standards that 
dictates specific behaviors and gives a detailed set of behavioral guidelines for a range of 
situations.  The distinctions between the code of ethics and the mandated standards indicate the 
potential for the two to dovetail nicely if used together to provide both broad concepts of ethical 
conduct for the practice of public health at the agency level with more specific guidelines for 
individual conduct in specific situations or employees of the Executive Branch of the 
government.  
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Figure 2: The Twelve Principles of the Ethical Practice of Public Health 
1. Public health should address principally the fundamental causes of disease and 
requirements for health, aiming to prevent adverse health outcomes 
 
2. Public health should achieve community health in a way that respects the rights of 
individuals in the community 
 
3. Public health policies, programs, and priorities should be developed and evaluated through 
processes that ensure an opportunity for input from community members 
 
4. Public health should advocate and work for the empowerment of disenfranchised 
community members, aiming to ensure that the basic resources and conditions necessary 
for health are accessible to all 
 
5. Public health should seek the information needed to implement effective policies and 
programs that protect and promote health 
 
6. Public health institutions should provide communities with the information they have that is 
needed for decisions on policies or programs and should obtain the community’s consent 
for their implementation  
 
7. Public health institutions should act in a timely manner on the information they have within 
the resources and the mandate given to them by the public 
 
8. Public health programs and policies should incorporate a variety of approaches that 
anticipate and respect diverse values, beliefs, and cultures in the community 
 
9. Public health programs and policies should be implemented in a manner that most enhances 
the physical and social environment 
 
10. Public health institutions should protect the confidentiality of information that can bring 
harm to an individual or community if made public.  Exceptions must be justified on the 
basis of the high likelihood of significant harm to the individual or others 
 
11. Public health institutions should ensure the professional competence of their employees 
 
12. Public health institutions and their employees should engage in collaborations and 
affiliations in ways that build the public’s trust and the institution’s effectiveness. 
6 
 
 In addition, within the federal workforce, there are examples of employees in other fields—such 
as physicians, other health care providers, and military personnel—who work for the federal 
government and are bound by both a professional oath or code of ethics and a mandated set of 
standards as would be the case for federal public health workers if the public health code of 
ethics is adopted by federal agencies.  However, one key difference is that the public health code 
of ethics is designed to guide the behavior and practice of institutions, while many other 
professional codes of ethics are aimed at guiding an individual’s behavior for ethical practice in a 
given field. 
The NIH and CDC are entrusted with the largest budgets in the Public Health Service to carry 
out and provide funding for a substantial portion of the country’s public health research and 
activities.  In addition, these agencies employ the majority of the federal public health workforce.  
It should follow that any code of ethics intended for public health institutions should be carefully 
considered by those in these agencies charged with developing and maintaining their ethics 
programs and examined for elements that may align with each agency’s mission, but may not be 
reflected in its current ethics programs.  This study reviews the current ethics practices and 
activities at CDC and NIH, assesses the extent to which the code’s principles align with the 
agencies’ missions and current ethics practices, assesses barriers to adopting the code, and 
describes the process for making changes to the ethics programs at CDC and NIH if gaps are 
identified. 
  
 
 
 
CHAPTER 2: REVIEW OF THE LITERATURE 
 
Before a study of how the public health code of ethics could be applied to the federal workforce 
can begin, it is important to ascertain whether the code of ethics is in conflict with the ethics 
rules that are legally required for federal workers.  This review of the literature is designed to 
address the question: Is the public health field’s movement to establish a public health code of 
ethics compatible with and distinct from the mandated standards of ethical behavior in place 
for employees within the U.S. Public Health Service?   Specifically, the review will address: 1) 
whether the code of ethics is compatible with mandated ethical standards such that the two 
would not be in conflict, and 2) whether it is distinct from the mandated ethical standards such 
that it could potentially fill gaps in the agencies’ current ethics programs and policies.   
Scope and Methodology 
The goal of this review is to search for all relevant sections of ethics legislation governing PHS 
employees and all published congressional (Legislative Branch) reports and studies of how PHS 
agencies have implemented the ethics legislation.  The purpose of reviewing this literature is to 
address whether and to what extent the proposed public health code of ethics is compatible with 
and is distinct from the standards for ethical behavior legislated for employees in the Public 
Health Service, and therefore could potentially add value to that segment of the workforce. In 
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addition, the review of literature will assess whether and to what extent the use of the code has 
been studied in or applied to federal public health agencies. 
By reviewing all sections of the Code of Federal Regulations that pertain to ethical conduct for 
Executive Branch employees and the published literature derived from congressional oversight 
of Executive Branch ethics programs, I expect to find information that will be useful in testing 
the following hypothesis: The public health code of ethics is compatible with and distinct from 
the standards for ethical behavior legislated for Executive Branch employees, and therefore, 
could be implemented to provide supplementary guidance to public health professionals 
employed in the PHS agencies. 
In order to address the key question, the approach to the literature review is two-fold.  First, the 
review will identify all relevant legislation that pertains to standards for ethical behavior for the 
federal public health workforce.  Included in the scope of the search are all sections of the Code 
of Federal Regulations that involve both Executive Branch employees and ethics or standards of 
conduct.  Second, the review will collect and analyze the published reports on congressional 
oversight of the Executive Branch ethics programs.  To accomplish this, the review will collect 
all relevant publications from the research and investigative arms of Congress: the Government 
Accountability Office (GAO) and the Congressional Research Service (CRS).  These two 
Legislative Branch agencies conduct policy research and oversight functions for committees and 
members of Congress.  The scope of the search includes all published GAO products (reports, 
correspondence, and testimony) and all publicly available CRS reports that are related to ethics, 
ethical behavior, ethics training, ethical standards, Office of Government Ethics, ethics 
programs, public health service ethics, codes of ethics, and ethical standards.   As a result of the 
review, I expect to have collected all relevant Federal legislation related to the legislated 
9 
 
standards for ethical behavior for Executive Branch 
employees as well as all congressionally-commissioned 
and published reports and evaluations of Executive 
Branch ethics programs.   
Search Terms and Criteria                                                                     
Included in the search are legislation and congressional 
oversight publications involving two general constructs 
that are key to my hypothesis: ethical standards and 
U.S. Public Health Service employees.  The search is 
designed to capture: 
• All relevant legislation governing ethical 
conduct of Executive Branch employees (and 
therefore all PHS employees), 
• All published GAO and CRS literature, 
investigations, testimonies and studies on how 
PHS agencies implement and enforce the 
legislated code of ethics, and 
• All relevant publications on the public health code 
of ethics in a search of the PubMed and Cumulative 
Index to Nursing and Allied Health databases. 
 
In order to find the relevant legislation, the review 
included a search of the Standards of Ethical Conduct 
for Employees of the Executive Branch (5 C.F.R. Part 
2635) for all sections and supplemental standards 
pertaining to the agencies within the scope of this study 
Figure 3: Definition of Key Terms 
Ethics: the framework to ensure 
the integrity of decision-making 
and behavior  
U.S. Public Health Service: the 
eight agencies within the 
Department of Health and Human 
Services, in the Executive branch 
of the federal government, whose 
focus is to conduct research and 
to provide funding, programs, and 
services to enhance the health of 
the population 
Legislated standards for ethical 
behavior:  the standards for 
ethical behavior mandated by law 
(under the 5 C.F.R. Part 2635) for 
employees of the Executive 
branch of the federal 
government, including the U.S. 
Public Health Service agencies  
Office of Government Ethics: 
Executive Branch agency 
established by the Ethics in 
Government Act of 1978 to 
prevent conflicts of interest on 
the part of government 
employees, and to resolve those 
conflicts of interest that occur 
Public health code of ethics: the 
twelve point code found within 
the Public Health Leadership 
Society’s Principles of the Ethical 
Practice of Public Health, Version 
2.2, published in 2002 (see Fig 1) 
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and excluded related authorities and supplemental standards which do not pertain to these 
agencies.  In order to find all relevant, published GAO and CRS literature, I have used search 
terms including ethics, ethical behavior, ethics training, codes of ethics, ethical standards, and 
other related terms (see Table 1).  
Table 1: Summary of Search Strategy 
Resource Search Terms Inclusion/ Exclusion Criteria 
 
5 C.F.R. Part 2635 - 
Standards of Ethical 
Conduct for 
Employees of the 
Executive Branch 
 
N/A: I performed a manual 
search of the sections of 
the regulation pertaining to 
PHS employees including 
the Agency Supplemental 
Standards of Conduct  
Include: general provisions, sections pertaining to 
specifics of standards of conduct for all Executive 
Branch employees, and supplemental standards of 
conduct for Public Health Service agencies 
Exclude: related statutory authorities and 
supplemental standards of conduct for Executive 
Branch agencies outside of  the Public Health Service  
 
Cumulative Index to 
Nursing and Allied 
Health 
 
 
• public health code of 
ethics 
• public health ethics 
Include: articles addressing public health ethics from 
an organizational or field perspective 
Exclude: articles written in other than English, articles 
with narrow focus on ethics pertaining to specific 
disease or condition 
 
PubMed  
 
 
• public health code of 
ethics 
• public health ethics 
Include: articles addressing public health ethics from 
an organizational or field perspective 
Exclude: articles written in other than English, articles 
with narrow focus on ethics pertaining to specific 
disease or condition 
 
GAO Publications 
Database 
 
• Ethical behavior 
• Ethics training  
• Ethics/Ethical 
standards 
• Office of Government 
Ethics 
• Ethics programs 
• Ethics 
Include: reports related to U.S. Public Health Service 
agencies, reports issued after the 2002 enactment of 5 
C.F.R. Part 2635 Standards of Ethical Conduct for 
Employees of the Executive Branch 
 
Exclude: reports related to agencies outside the 
Executive Branch, reports issued prior to enactment of  
Standards 
 
Open CRS Network 
Databasea 
 
• public health service, 
ethics 
• codes of ethics 
• ethical standards 
• ethics  
Include: reports related to U.S. Public Health Service 
agencies, reports issued after the 2002 enactment of 5 
C.F.R. Part 2635 
Exclude: reports related to agencies outside the 
Executive Branch, reports issued prior to enactment of  
Standards 
a Open CRS Network is a repository for reports and policy briefs published by the CRS. 
Since the focus of the review is on Executive Branch experience under the current mandated 
standards for ethical behavior, the review includes only the literature published after the 
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standards were codified in October 2002.  Table 1 provides a summary of the search terms, 
inclusion criteria, and exclusion criteria used in this review. 
 
Results 
The search included the key components of relevant federal legislation and congressionally-
commissioned and published literature on PHS ethics programs and yielded 52 relevant items 
including 16 sections of the Standards of Ethical Conduct for Employees of the Executive Branch, two 
GAO products, one CRS product, and 33 other items on public health ethics.  Table 2 provides a 
summary of the number of search results with a narrative description of results by resource. 
Table 2: Summary of Search Results 
Resource Terms Total 
Search 
Results 
Inclusion/ Exclusion Criteria Relevant 
Search 
Results 
5 C.F.R. Part 
2635 - Standards 
of Ethical 
Conduct for 
Employees of the 
Executive 
Branch 
N/A: I performed a 
manual search of the 
sections of the 
regulation pertaining 
to PHS employees 
including the 
Agency 
Supplemental 
Standards of 
Conduct 
 
 
 
44 
Include: general provisions, sections 
pertaining to specifics of standards of 
conduct for all Executive Branch 
employees, and supplemental standards of 
conduct for Public Health Service 
agencies 
Exclude: unrelated statutory authorities, 
and supplemental standards of conduct 
for Executive Branch agencies outside of 
the PHS 
 
 
 
16 
Cumulative 
Index to Nursing 
and Allied 
Health 
 
• Public Health 
Code of Ethics 
• Public health 
ethics 
 
19 
Include: articles addressing public health 
ethics from an organizational or field 
perspective 
Exclude: articles written in other than 
English, articles with narrow focus on 
ethics pertaining to specific disease or 
condition 
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• Public Health 
Code of Ethics 
• Public health 
 
 
Include: articles addressing public health 
ethics from an organizational or field 
perspective 
 
 
12 
 
PubMed ethics 95 Exclude: articles written in other than 
English, articles with narrow focus on 
ethics pertaining to specific disease or 
condition 
25 
 
 
GAO 
Publications 
Database  
• Ethical 
behavior or 
conduct 
• Ethics training  
• Ethics/Ethical 
standards 
• Office of 
Government 
Ethics 
• Ethics 
programs 
• Ethics 
2 
 
1 
1 
8 
 
1 
5 
Include: reports related to PHS agencies, 
reports issued after the 2002 enactment of 
5 C.F.R. Part 2635 Standards of Ethical 
Conduct for Employees of the Executive 
Branch 
Exclude: reports related to agencies 
outside the PHS, reports issued prior to 
enactment of  Standards 
 
 
 
2 
 
Open CRS 
Network 
Database 
 
• public health 
service ethics 
• codes of ethics 
• ethical 
standards 
• ethics 
1 
0 
1 
6 
Include: reports related to U.S. Public 
Health Service agencies, reports issued 
after the 2002 enactment of Standards 
Exclude: reports related to agencies 
outside the PHS, reports issued prior to 
enactment of  Standards 
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Standards of Ethical Conduct for Employees of the Executive Branch (5 C.F.R. Part 2635) 
The search revealed 16 sections of the Standards that pertain to ethical conduct for Executive 
Branch employees.  These sections outlined specific rules and guidance on issues such as 
accepting gifts from outside sources, exchanging gifts among employees, conflicting financial 
interests, impartiality in performing official duties, seeking outside employment, misuse of 
position, and outside activities.  The relevant sections offer detailed guidance for employees 
about what constitutes ethical and appropriate behavior. 
 
GAO Reports 
The review included two reports issued since 2002—when the Standards of Ethical Conduct for 
Employees of the Executive Branch were codified—that addressed Public Health Service agency 
ethics programs.  One report studied the NIH policies on recusal from work that may affect a 
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personal interest (U.S. Government Accountability Office, April 30, 2007).  The report found 
that the agency had not established clear policies on recusal for senior executives and culminated 
in a recommendation that the NIH Director address inconsistencies in the policy and 
expeditiously issue a clarified policy.  In addition, the background section of the report provided 
details regarding NIH’s overall ethics training and policies.  A second report studied conflicts of 
interest among Food and Drug Administration3 advisory committee members, specifically, their 
financial disclosures with regard to interest that may be related to or impacted by outcomes of 
Advisory Committee deliberations and recommendations (U.S. Government Accountability 
Office, September 30, 2008). This report also provided general description and information on 
the agency’s implementation of ethics policies and programs. 
CRS Report 
The review included one report issued since 2002 that addressed Public Health Service agency 
ethics programs.  The report entitled The National Institutes of Health: Organization, Funding, 
and Congressional Issues, studied the NIH’s ethics and accountability programs and the 
agency’s efforts to ensure the public’s trust (Congressional Research Service, 2008).  The report 
cited oversight of ethics regulations for the agency and its program to grant the public access to 
NIH funded research as issues of particular importance to members of Congress.  The report 
tracked the progress of implementing several provisions within the NIH Reform Act of 2006 and 
covers several areas of Congressional oversight of the agency, including activities aimed at 
maintaining trust and transparency.4  
                                                           
3 The Food and Drug Administration is an agency within the Department of Health and Human Services’ U.S. 
Public Health Service. 
4 P.L. 109-482, December 2006. 
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PubMed and CINHAL Searches 
The literature discovered in searches of the PubMed and CINHAL databases addressing the 
public health code of ethics for the most part falls into two categories: 1) articles in which the 
author applies an ethical framework to a particular disease or condition (Melnick, Kaplowitz, 
Lopez, & Murphy, 2005; Miller, Robert, & Hayeems, 2009; Thomas, Irwin, Zuiker, & Millikan, 
2005a; Thomas, Dasgupta, & Martinot, 2007) and 2) articles in which the development of a 
public health ethical framework or its applicability in public health education or training is 
discussed (Ruger, 2008a; Ruger, 2008b; Stadtländer & Dickens, 2005; Thomas, 2003).  The literature 
reviewed from these searches revealed no substantive discussion of the utility, adoption, or use 
of the code of ethics in federal agencies.   
 
Findings 
The review of the literature yielded information that was necessary to address the question:  Is 
the public health field’s movement to establish a public health code of ethics compatible with 
and distinct from the mandated standards of ethical behavior in place for employees within the 
U.S. Public Health Service?  In addition, the review provided insights into whether and to what 
extent the use of the code of ethics has been studied in the federal workforce. 
Finding #1: The Public Health Code of Ethics is Compatible with the Legislated Standards 
of Ethical Behavior in Place for Employees within the U.S. Public Health Service  
None of the elements addressed in the public health code of ethics is in conflict with the 
legislated standards in place for employees within the U.S. Public Health Service. A review of 14 
sections of the Standards of Ethical Conduct for Employees of the Executive Branch and the two 
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relevant supplemental standards pertaining to PHS agencies and employees revealed that specific 
items addressed— such as financial conflicts of interest, outside employment, ethics training, 
and misuse of position— do not conflict with the general guidance set forth in the public health 
code of ethics.  Further, some of the concepts found in the public health code of ethics reinforce 
sections of the regulations, indicating that they are, in fact, compatible.  For example, the twelfth 
principle in the code of ethics focuses on the importance of public health institutions and their 
employees building the public’s trust and the institution’s effectiveness(Public Health Leadership 
Society, 2002).  This tenet is central to the standards mandated for Executive Branch employees.  
In fact, the first line of the first section of the regulation states, “Public service is a public trust”(5 
C.F.R., 2002; 5 C.F.R., 2002).  Another principle in the public health code of ethics stresses the 
need to maintain confidentiality of information to protect the privacy of individuals.  This 
reinforces the mandate in the Standards that states that “employees shall not allow improper use 
of non-public information”(5 C.F.R., 2002).  The two documents share some overlapping themes 
without contradicting each other, indicating their compatibility.  In general, the standards 
mandated for PHS employees are compatible with and are reinforced by the principles advocated 
in the public health code of ethics. 
Finding #2: The Public Health Code of Ethics is Distinct from the Legislated Standards of 
Ethical Behavior in Place for Employees within the U.S. Public Health Service  
 The public health code of ethics is distinct from the Standards of Ethical Conduct for Employees 
of the Executive Branch in that they have separate areas of focus.  The code of ethics is 
aspirational and provides broad guidance about the practice of public health aimed primarily at 
institutions, while the Standards are proscriptive and focus on the behavior of individual 
employees, giving guidance for specific sets of circumstances.  A review of the 14 sections of the 
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Standards of Ethical Conduct for Employees of the Executive Branch and the two relevant 
supplemental standards pertaining to PHS agencies and employees revealed that the legislated 
standards are focused on rules regarding several specific circumstances— such as giving and 
receiving gifts and use of government property.  The oversight literature from GAO and CRS 
provides further evidence that the focus of the Standards is distinct from the broad concepts 
outlined in the code of ethics.  In one GAO report, the agency recommends that NIH clarify its 
policy on employee recusals from work that will affect a personal interest(U.S. Government 
Accountability Office, April 30, 2007).  While this concept has some element of preserving the 
public’s trust, its focus on a policy for employees to evaluate an individual relationship to a 
project or aspect of work is distinct from the code of ethics’ focus on agency or institution-wide 
philosophy of involving community to build public trust.  Given their separate missions—to 
provide broad guidance to institutions in the case of the code of ethics and the establishment of a 
code of conduct that prescribes specific behaviors in the case of the Standards—the two 
documents are distinct and serve different, yet complimentary purposes.  
Finding #3: There has been very little study of the use and applicability of the public health 
code of ethics in federal agencies. 
The literature review reveals that there has been very little study of the use and applicability of 
the public health code of ethics in federal agencies.  The literature addressing the public health 
code of ethics typically focuses on 1) the application of an ethical framework to a particular 
disease or condition or 2) the development of a public health ethical framework or its 
applicability in public health education or training.  The literature review revealed little 
discussion of the examination or use of the code of ethics in any of the federal agencies.   
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Discussion 
The literature on the use of the public health code of ethics discovered in this review generally 
falls into two categories: 1) articles in which the author applies an ethical framework to the 
management of a particular disease or condition or studies how others use ethical guidelines to 
do so and 2) articles in which the development of a public health ethical framework or its 
applicability in public health education or training is discussed.  Examples of the first category 
include a study by Baum, et.al. in which public health workers in Michigan identified broad 
categories of ethical challenges and revealed that few used formal ethical guidelines or 
frameworks in their decision-making(Baum, Gollust, Goold, & Jacobson, 2009). Other examples 
include work by Thomas which considers how the public health code of ethics might reveal 
important considerations in the use of genomic technologies(Thomas, Irwin, Zuiker, & Millikan, 
2005b) as well as his analysis of federal and state pandemic influenza plans which for the most 
part lacked guidance for ethical decision-making in the event of an outbreak(Thomas et al., 
2007).  In addition, Brody, et.al. discuss several frameworks—clinical expert-driven, activist, 
and the community-based participatory research model— that can be applied when making 
ethical decisions about studying biological samples and reporting results of individual exposure 
to pollutants(Brody et al., 2007).  There were several illustrations of the second category of 
articles describing how ethics is taught to students of public health and how those in the field are 
trained and supported (or should be) in their ethical decision-making.  MacQueen, et.al. makes 
an argument for greater oversight of public health ethics and for recognition of public health 
ethics as a distinct field which draws from several disciplines including bioethics, law, and 
political philosophy(MacQueen & Buehler, 2004). Several of the articles highlight the important 
distinctions between medical and public health ethics—primarily that the medical and bioethical 
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perspective involves the interaction between individuals (doctor/patient, researcher/subject), 
while the public health model focuses on the interactions between institutions and the 
populations they serve (public health programs/communities).  Bayer and Fairchild describe a 
“deep divide” between the commitments and values of bioethics and public health practice by 
way of advocating that public health should have its own, unique ethical framework, separate 
from the bioethical model(Bayer & Fairchild).  The literature review revealed no substantive 
discussion of the use of the code of ethics in federal agencies.  One exception is an article 
describing the CDC’s efforts to strengthen the agency’s leadership in public health 
ethics(July/August 2008). According to Barrett, the effort is centered on building an 
administrative infrastructure for ethics within the agency and for applying public health ethics to 
particular program concerns within the agency.   
Strengths and Limitations of the Literature 
After determining that the public health code of ethics and the Standards of Ethical Conduct for 
Employees of the Executive Branch are complimentary and distinct, it is useful to examine the 
quality of literature on which these conclusions are based.  There are several strengths and 
weaknesses that should be taken into account when considering these findings.   
An advantage of using GAO and CRS published literature to learn about the implementation and 
effectiveness of Executive Branch ethics programs is that those Legislative Branch agencies have 
greater access to Executive Branch agency information than would a researcher relying on 
publicly available data or requests for data made through the Freedom of Information Act.5  In 
addition, the GAO has subpoena power to obtain relevant information from agencies it studies in 
                                                           
5 The Freedom of Information Act allows for the release of previously unpublished information controlled by the 
U.S. government and ensures public access to some government records. 
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order to fulfill a congressional request. The result of this enhanced access, is that the studies can 
include documentation, interviews, and other data from Executive Branch agencies to which 
researchers outside of GAO and CRS would not have access.  
While the increased access to information is a strength of GAO and CRS literature, the nature of 
how the studies are commissioned presents a critical limitation.  With some limited exceptions, 
the studies conducted by these agencies are in response to congressional requests, often to 
provide an evidence-base for potential legislation or to inform a particular political agenda.  In 
conducting the studies, GAO and CRS are not always at liberty to pursue other avenues that arise 
during the research phase of a study or explore related topics that fall outside of a tightly 
managed scope of study.  While the studies are conducted within a system with rigorous controls 
to ensure non-partisan and balanced research, there is limited freedom to shape the research 
agenda.6   Another limitation of this review is incomplete access to all CRS products.  Because 
CRS publications are not routinely released to the public by the agency or by the members of 
Congress who requested them, it is not possible to review the universe of CRS publications on a 
given topic.  A requester may elect to publicize a report, but is not obligated to do so.  This 
review included a search of the Open CRS Network which was established to collect and make 
available any CRS publications voluntarily released by congressional requesters. There is no 
repository for all CRS publications, so the review included a search of only those that have been 
released to the public.  Finally, a lack of published literature on how the public health code of 
ethics is used in federal agencies may not adequately capture current practice.  It is possible—
and perhaps likely—that internal discussions and policy formulation regarding federal ethics 
programs would not result in peer reviewed, published literature, but rather would be 
                                                           
6 In the case of GAO, a small portion of the work conducted is identified by the agency as opposed to a 
congressional requester. 
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documented in internal agency materials that may or may not be available to the public. 
 
Gaps in the Literature and Considerations for Future Research 
None of the products reviewed from GAO and CRS directly addressed the relationship between 
professional codes of ethics—such as the one for public health or for medical personnel—and 
mandated codes or standards of ethics.  The articles selected for this review contained research 
findings and discussion of federal ethics issues and programs specific to individual agencies and 
did not address Executive Branch workforce in general. These gaps in the literature revealed 
some areas for future study that I will consider for the dissertation.  First, the lack of published 
literature on how the public health code of ethics is used in federal agencies indicates that the 
strategy of conducting key informant interviews and reviewing available documentation about 
agency ethics programs may be more effective means of capturing current practice.  Another 
area for future study is consideration of lessons that might be learned from a comparison of the 
interplay between professional codes of ethics and mandated ethical standards for other 
professions that are similarly rooted in the federal government such as medicine.
  
 
 
 
CHAPTER 3: METHODS 
 
The research design and analysis undertaken for this study were intended to address the study’s 
key research questions: 
• In the context of the 12 principles of the public health code of ethics, what are the current 
practices of the CDC and NIH, the two largest federal public health agencies?    
• To what extent has the public health code of ethics been given specific consideration by 
the two largest federal public health institutions?   
• If benefits are identified, how can specific barriers to implementing the code of ethics be 
addressed to fill gaps in the agencies’ current ethics programs? 
By combining methods for data collection—document review and key informant interviews— 
the information gathered was triangulated.  This allowed for information gathered by employing 
one method to be corroborated and verified by information collected by the other method. 
Section I: Data Collection 
To learn about the CDC’s and NIH’s current practices, how they align with the public health 
code of ethics, and how changes to the ethics programs could be implemented, I employed a 
sequential information-gathering strategy involving document review and key informant 
interviews (see Figure 4).  First, I conducted a search for publicly available information for the 
CDC and NIH regarding the current programs, policies, guidelines, and procedures for ethically 
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conducting their public health missions.  I compared this information with the 12 principles in 
the public health code of ethics in order to identify particular areas where gaps between the 
code’s principles and the agencies’ programs may exist.  I used that analysis to inform and refine 
a set of questions for interviews with agency officials.   
Figure 4: Concept Model for Data Gathering     
 
Next, I conducted key informant interviews with ethics personnel from CDC and NIH.  The 
interviews were used to verify and clarify the information from the first phase of document 
review and to ascertain study participants’ opinions of the code of ethics and whether they think 
it includes principles that could address gaps in and be added to the current agency ethics 
programs and policies.  I also explored what the barriers are to adopting the principles of the 
code of ethics in each agency.  One of my goals for the key informant interviews and document 
review was to understand how a change to each agency’s ethics program would happen—who 
the decision-makers are, what the steps would be for change, what the barriers are, etc.  An 
additional goal was to determine whether there are principles within the code of ethics that may 
not be currently covered in the agencies’ ethics programs, and if so, whether officials believe 
there would be a benefit to addressing them.  Finally, after analyzing information from both 
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methods of data collection, I determined what a reasonable strategy would be for incorporating 
any relevant changes into the fabric of the agency. 
Because decision-making procedures between the two agencies in this study are rarely 
formalized in public documents, interviews were a vital research tool to learn the agencies’ 
processes for making changes to their ethics policies.  As appropriate, I requested documentation 
to support participants’ responses.  The final stage of data gathering was a second phase of 
document review wherein I collected documentary support from interview participants during 
the course of the interviews and reviewed and analyzed that information to further verify the 
information gained from the first two stages of data collection.  While study participants did not 
provide sensitive agency materials, in the course of the interviews, they did identify and offer 
documents or support materials that were useful for this study, and were not available through a 
search of agency web sites. This set of documents was predictably small, but did yield some 
significant insight into the CDC’s process for educating its workforce about the code of ethics.  
For example, a CDC official shared an internal survey used to determine familiarity with and 
attitude about the public health code of ethics that was currently being fielded with the agency’s 
employees.  This document was not posted on the agency web site and was not otherwise 
available to the public. 
Study Participants and Recruitment 
Study participants included individuals with professional responsibility for developing, 
conducting training about, and overseeing ethics programs and policies at the two largest federal 
public health agencies—CDC and NIH.  In addition, the study included participants who were 
instrumental in developing the public health code of ethics, knowledgeable about its history, or 
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actively working to disseminate the code.  Fourteen potential participants were identified through 
initial document review and through personal contacts and were invited to serve as key 
informants for the study, including ethics officials from CDC, NIH, and HHS and individuals 
who participated in the development of the code of ethics.  Potential participants were selected 
for their knowledge of ethics programs and internal process for adapting those programs at CDC 
or NIH.  In addition, participants were selected for their direct experience in the development 
and/or dissemination of the code.   
Table 3: Invited Study Participants, Affiliations, and Interview Status 
Invited Participant Affiliation Interview Status 
Dr. Drue Barrett 
CAPT, U.S. Public Health Service 
Public Health Ethics Coordinator 
Office of the Chief Science Officer 
CDC Completed 
Ruth Gaare Bernheim, J.D. 
CDC Public Health Ethics Committee 
Co-Chair, PHLS Public Health Ethics Committee 
CDC / PHLS  Completed 
Vence Bonham, J.D. 
Associate Investigator and Senior Advisor to the Director 
on Societal Implications of Genomics 
Branch Chief, Education and Community Involvement 
National Human Genome Research Institute 
NIH Completed 
Terry Brandenburg, MPH, CPH 
Former Board member 
Public Health Leadership Society 
PHLS 
 
  
Completed 
Dr. Christine Grady 
Acting Chief, Department of Bioethics 
Head, Section on Human Subjects Research 
NIH Completed 
Holli Beckerman Jaffe, J.D. 
Senior Policy Officer, NIH Ethics Office 
Deputy Ethics Counselor, Office of the Director 
NIH Completed 
Dr. Lisa M. Lee 
Assistant Science Officer 
Former Ethics Coordinator 
CDC Completed 
Dr. Alan Melnick 
Co-Chair, PHLS Public Health Ethics Committee 
PHLS  Completed 
Gretchen H. Weaver, J.D. 
Senior NIH Ethics Counsel 
Department of Health and Human Services, Ethics Division 
NIH/ 
HHS 
Completed 
Representative CDC/PHLS Scheduled, but not completed 
Four Representatives PHLS No response 
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Ten invitees agreed to be interviewed for this study with nine completing an interview.  Of the 
fourteen who were invited, one respondent agreed to be interviewed, but did not complete an 
interview, and four invitees—all from the Public Health Leadership Society (PHLS)—did not 
respond to the invitation.  Table 3 provides a list of key informants and others invited to 
participate, their affiliation as it pertains to the topics addressed in the study, and the status of 
their participation. 
Interviews were conducted by telephone between March 3, 2010 and April 15, 2010 and were 
recorded with the permission of the participants.  Procedures and written information provided to 
the potential participants were approved by the University of North Carolina Institutional Review 
Board (IRB).  To recruit key informants, I sent an e-mail explaining the research study and 
asking whether selected individuals would be willing to participate in an interview to discuss the 
public health code of ethics and their respective agency’s ethics programs or their role in the 
development and dissemination of the code.  For those willing to participate, I scheduled an 
interview and sent a fact sheet (see Appendix A) and the public health code of ethics in advance 
of the discussion.  The procedure for participants was as follows: 
• Read the fact sheet to determine interest in participating in the study 
• Contact the researcher with any questions or concerns regarding participation 
• Schedule a time to participate in a 30-45 minute telephone interview7  
• Read the 12 principles of the code of ethics entitled Principles of the Ethical Practice of 
Public Health before the interview and consider whether or how it aligns with the 
participant’s agency mission  
• Participate in a 30-45 minute interview  
                                                           
7 This time was adjusted from the original fact sheet request for a 45-60 minute interview. 
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• Address follow up questions or clarifications if needed after the interview 
 
Individuals were informed that they may benefit from participation in this study by discovering 
ways the public health code of ethics could enhance the current ethics programs and policies in 
place within the agency where the participant is employed.  The interviews with key informants 
(federal agency officials and others), were designed to elicit and clarify details regarding ethics 
programs, policies, and practices within their agencies or organizations.  These programs are, by 
their very nature, public, and so participation was unlikely to pose a risk. However, any potential 
risk was mitigated by allowing participants to opt for confidentiality of information, in which 
case I would not identify the name, position, or any other element that may allow the reader to 
ascertain the identity of individual participants in the report of study results.  All participants 
agreed to have their names used to affirm their participation; however, several participants asked 
not to have quotations attributed to them.  As a result, all direct quotations from key informants 
included in the results of this study are characterized to describe the speakers’ affiliation, but not 
directly attributed to participants by name.   
 
Interview Format and Privacy of Information 
When participants agreed to be interviewed for the study, I made appointments in advance with 
the key informants, allowing them the opportunity to schedule the interview at a time convenient 
for them to participate in a 30-45 minute discussion by telephone.  The interviews proceeded 
according to the interview protocol approved by the IRB with questions that moved from general 
to specific and follow the following question scheme: 
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• Opening: to ease the participant into discussion with a question about her/his role in the 
agency’s ethics program; 
• Introductory: a broad question to check familiarity with the public health code of ethics;  
• Key Questions: the questions that are the crux of the interview and are the most important 
since they directly address the study’s key research questions;  and 
• Ending: a request to prioritize earlier responses, clarify any information from the 
interview, and an invitation to indicate any other areas of inquiry or agency contacts that 
may be relevant to the study. 
The framework used for sequencing, phrasing, and delivery of interview questions is consistent 
with best practices for qualitative research and is modeled on the concepts for developing 
qualitative questioning routes for key informant and focus group interviews (Krueger, Richard A. 
and Casey, Mary Anne, 2000; National Cancer Institute, 2002).  The interviews concluded with a 
request for permission to contact the participant in the future if additional questions or need for 
clarification arose.  During the interviews, participants were asked whether there was 
documentation they could share to support certain responses.  This yield a small, but insightful 
collection of documents that are not posted publicly, but are not classified or sensitive and could 
therefore be made available for this study.   
Prior to beginning the interview questions, I asked the interviewees for permission to audio 
record the discussion for later transcription.  Participants had received a full written description 
of the study prior to the key informant interviews and had an opportunity to ask questions and/or 
express concerns via e-mail or telephone prior to scheduling the initial interview as well as at the 
outset of the interview appointment.  In addition, I obtained the participants’ verbal consent to 
participate at the time of the interview, prior to any data collection.  
In general, the study discusses interview results in the aggregate, attributing statements to 
“officials at NIH” or “CDC ethics staff.”  In some cases, in order to demonstrate the credibility 
of a statement or to provide evidence that a statement was given from a person with the 
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appropriate experience, training, or position to speak with authority on a topic, I attributed 
statements to a particular individual by describing the participant’s position when the participant 
granted permission.  I asked research participants for permission to attribute statements and 
information shared in the interview, resulting in some granting permission and others asking to 
review specific statements prior to attribution.  Other procedures for assurance of privacy 
included: 
• The principal investigator is the only person who has access to information that links 
individual participants to the responses from their interviews.  
• Participants were asked for permission before being identified in the study.   
• Records of the interview are stored electronically in protected files.  
• At the time of the interview, participants were asked for permission to record the interview 
for transcription. All interviews were recorded, and a written transcript was made and stored 
securely. 
• Any hardcopy information linked to an individual’s responses to interview questions were 
stored in a secure location.  
 
There were no monetary or explicit non-monetary incentives to participate in this study, other 
than my offer to provide a copy of the completed work after committee approval.  In addition, 
there were no costs to be borne by subjects, other than their time. 
Special considerations 
Disclosure of GAO employment 
The agency where I am employed—the GAO— serves an oversight function for the Executive 
Branch, including the two agencies within the scope of this study.  I disclosed my professional 
affiliation to each participant and assured those invited to be interviewed that any data collected 
for this project would not be shared with GAO for any active engagement.  The disclosure did 
not result in any interviewees changing their minds about participating in the study nor did it 
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appear to have an impact on the candor with which participants spoke about their agency’s ethics 
programs and activities. 
Affirmation of non-advocacy stance 
I made clear to research participants that I am not involved in the writing or dissemination of the 
public health code of ethics and that I do not have a stake in its acceptance or failure.  The study 
explores how the public health code of ethics could be used to fill gaps in ethics programs at NIH 
and CDC and is not designed to advocate for its adoption in the federal system.  However, the 
participants were informed that study findings may lead to recommendations for the code as a 
whole or for particular principles of the code to be adopted or addressed by the agencies if gaps 
are found. 
 
Document Review 
Given that the document review was performed to ascertain the extent to which the CDC and 
NIH have programs, policies, and practices in place to address the 12 principles in the code, the 
code itself served as the framework for the search for documents on the web sites of each 
agency.  The sources for the search for documents and other publicly available information on 
the agencies’ ethics activities included the CDC and NIH web sites and Google.  The search 
terms and system for capturing documents for this study are summarized in Table 4. In addition 
to a systematic search using the terms noted in Table 4, the search for documents and other 
information included reading widely on both the CDC and NIH web sites and from the material 
found as a result of Google searches.   
30 
 
The goal of the document review was not to catalog all programs that relate to the code’s 
principles, but rather to indicate whether any agency programs or activities could be linked to 
each principle. In some cases, there were numerous programs that pertained to a given principle, 
in which case only a few were selected for inclusion in the study findings.  In this case those with 
agency-wide focus were given preference over those carried out at the institute or division level.  
For example, the first portion of principle 6 reads, “Public health institutions should provide 
communities with the information they have that is needed for decisions on policies or 
programs.”  When searching for examples of programs that address this concept, numerous 
public health and education materials and campaigns surfaced such as those translating research 
into messages regarding heart health, nutrition, diabetes treatment and prevention, etc.  Rather 
than list the many examples that exist at the institute level, the study focuses on the policies that 
exist agency-wide to address this principle. 
Table 4: Search Terms and Sources Used for Collecting Documents on CDC and NIH 
Ethics Activities  
Public Health Code of Ethics Principlesa Search terms used on CDC and 
NIH web sites and Googleb 
1) Public health should address principally the fundamental 
causes of disease and requirements for health, aiming to 
prevent adverse health outcomes 
• “causes of disease” 
• prevention 
• “adverse health outcomes” 
2) Public health should achieve community health in a way that 
respects the rights of individuals in the community 
• “community health” 
• “rights of individuals”; “individual rights” 
3) Public health policies, programs, and priorities should be 
developed and evaluated through processes that ensure an 
opportunity for input from community members 
• “community input” 
• input; feedback 
4) Public health should advocate and work for the 
empowerment of disenfranchised community members, aiming 
to ensure that the basic resources and conditions necessary for 
health are accessible to all 
• “minority health”; minority 
•  “health disparities”; disparities 
5) Public health should seek the information needed to 
implement effective policies and programs that protect and 
promote health  
• “health promotion” 
 
6) Public health institutions should provide communities with 
the information they have that is needed for decisions on 
policies or programs and should obtain the community’s 
consent for their implementation 
•  “community consent”; consent 
7) Public health institutions should act in a timely manner on • communication 
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the information they have within the resources and the mandate 
given to them by the public 
• results 
8) Public health programs and policies should incorporate a 
variety of approaches that anticipate and respect diverse values, 
beliefs, and cultures in the community 
• “minority health”; minority 
•  “health disparities”; disparities 
9) Public health programs and policies should be implemented 
in a manner that most enhances the physical and social 
environment 
• “environmental health” 
• environment  
10) Public health institutions should protect the confidentiality 
of information that can bring harm to an individual or 
community if made public.  Exceptions must be justified on the 
basis of the high likelihood of significant harm to the individual 
or others 
• “human rights” 
• “human subjects” 
• consent 
11) Public health institutions should ensure the professional 
competence of their employees 
• “staff education” 
• development 
• training 
12) Public health institutions and their employees should 
engage in collaborations and affiliations in ways that build the 
public’s trust and the institution’s effectiveness. 
• “public trust” 
• partnership 
a Principles of the Ethical Practice of Public Health, Public Health Leadership Institute, 2002. 
b Search terms were the same for the agency web sites and for Google except that for Google searches, terms were 
preceded by the agency acronym (CDC or NIH). 
 
 
Section II: Data Analysis  
Qualitative primary data was collected for this study from key informant interviews, the analysis 
of which paralleled the key research questions.   All recorded interviews were transcribed and 
printed for analysis.  Responses were reviewed and manually coded by the major themes covered 
in the interview protocol and key research questions including: current practices within CDC and 
NIH that address the principles within the code, familiarity with the code of ethics, deliberation 
within the CDC and NIH regarding adoption of the code, barriers to adopting the code, and the 
processes within CDC and NIH for making changes to the ethics programs when gaps are 
identified.  Table 5 summarizes these themes as well as those derived from the document review 
and relates them to the key research questions. 
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Table 5: Summary of Key Themes Analyzed and Their Relationships to Key Research 
Questions 
Key Themes Analyzed Addressed 
by 
Interviews 
Addressed 
by Doc 
Reviews 
Key Research Question 
Addressed 
CDC and NIH ethics practices/ 
programs 
X X Question 1: current practices 
that address the code 
Familiarity with code X X Question 2: adoption of code 
considered 
Whether adoption of code was 
discussed within agencies 
X n/a Question 2: adoption of code 
considered 
Barriers to adopting the code X n/a Question 3: how barriers can 
be addressed/changes made 
Agency processes for changing 
ethics programs 
X n/a Question 3: how barriers can 
be addressed/changes made 
 
Secondary data was collected in the form of two phases of document review and analysis: phase 
one (prior to key informant interviews) based upon publicly available documents regarding the 
agencies’ ethics programs and policies and phase two based upon documents requested from or 
offered by key informants during the course of interviews. The analysis for this study flowed 
from the three data collection stages and was performed concurrently with data collection (see 
Figure 5).   
Figure 5: Concept Model for Data Analysis 
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The information from the first phase of document review was used to perform side-by-side and 
gap analyses to: 1) determine what the current ethics practices are in each agency and compare 
them side-by-side with the twelve principles of the code of ethics, and 2) identify any gaps, or 
principles of the code of ethics not currently addressed by the agencies.  These analyses helped 
to inform the interviews with key informants.  Through the course of the interviews, participants 
offered or I requested documentation to support participants’ responses to interview questions 
and to further illustrate points they raised in the discussion.  Interviews and the second phase of 
document review informed revisions to the gap analysis of the code of ethics and current agency 
practices.  This analysis led to categorization by themes expressed in the research questions into 
findings and subfindings, a discussion of the findings, a presentation of conclusions, and a plan 
for change.   
  
 
 
CHAPTER 4: RESULTS 
OUTLINE 
Introduction 
Section I: Key Informant Interview Findings 
? Description of Sources 
 
? Key Findings 
 
? Key Question 1: In the context of the 12 principles of the public health code of ethics, 
what are the current practices of the CDC and the NIH, the two largest federal public 
health agencies?    
? Key finding 1.1:  Information collected from key informants affirmed that CDC 
and NIH have ethics programs and activities that address all or most of the 12 
principles of the public health code of ethics 
• Subfinding 1.1.a: CDC officials described programs and activities that 
address all of the principles in the code of ethics 
• Subfinding 1.1.b:  NIH officials described programs and activities that 
address ten of the principles in the code of ethics 
 
? Key Question 2: To what extent has the public health code of ethics been given specific 
consideration by the two largest federal public health institutions?  
? Key finding 2.1: Familiarity with the public health code of ethics varied 
dramatically between agencies: All CDC officials and associates interviewed for 
this study were familiar with the public health code of ethics, and none of the 
NIH officials had seen or heard of the code before being interviewed for this 
study 
? Key finding 2.2: The CDC has considered formally adopting the code and has 
declined to do so 
? Key finding 2.3: Officials at both agencies identified potential barriers to 
adopting the code, leading to mixed opinions about the benefit of doing so 
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• Subfinding 2.3.a: CDC and NIH officials identified legal obligation and 
agency authority as barriers to adopting the code 
• Subfinding 2.3.b: CDC and NIH officials recognized the lack of a clearly 
articulated rationale for the code as a barrier to its adoption 
 
? Key Question 3: If benefits are identified, how can specific barriers to implementing the 
code of ethics be addressed to fill gaps in the agencies’ current ethics programs? 
? Key Finding 3.1: The CDC and NIH each has a process for considering additions 
or changes to agency ethics programs which would allow gaps in their programs 
to be addressed. 
 
Section II: Document Review Findings 
? Description of sources 
 
? Key Findings 
 
? Key Question 1: In the context of the 12 principles of the public health code of ethics, 
what are the current practices of the CDC and Prevention and the NIH, the two largest 
federal public health agencies?    
? Key finding 1.2:  There are programs at CDC and NIH that address most of the 
12 principles of the public health code of ethics  
• Subfinding 1.2.a: CDC documents show that the agency has programs and 
activities that address most of the principles in the code of ethics 
• Subfinding 1.2.b: NIH documents show that the agency has programs and 
activities that address most of the principles in the code of ethics 
• Subfinding 1.2.c: The review of publicly available documents revealed some 
gaps between agency ethics programs and the public health code of ethics 
 
36 
 
 
The key informant interviews and document review were designed to provide insights into the 
study’s three key questions from different perspectives.  The goal of the key informant 
interviews, was to develop an understanding of each agency’s organization, resources, and 
practices devoted to addressing the principles within the public health code of ethics and to tap 
into any information not readily available through a search of publicly available information.  
The objectives of the document review were to provide an agency-level overview of 
organizational components, programs, and policies that address the principles in the public health 
code of ethics, to illuminate any potential gaps between the code’s principles and the agency’s 
practices, and to determine targeted areas of questioning for key informant interviews with 
agency officials. The findings of both study components –the key informant interviews and the 
document review—are summarized along that analytical framework in this chapter. 
 
The three key research questions for this study are:  
• Key Question 1: In the context of the 12 principles of the public health code of ethics, 
what are the current practices of the CDC and the NIH, the two largest federal public 
health agencies?   
• Key Question 2: To what extent has the public health code of ethics been given specific 
consideration by the two largest federal public health institutions?  
• Key Question 3: If benefits are identified, how can specific barriers to implementing the 
code of ethics be addressed to fill gaps in the agencies’ current ethics programs? 
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The goal of the key informant interviews was to address the latter two key questions by 
determining current practices, whether either of the agencies has considered formally adopting 
the code of ethics, what the barriers are to doing so, and what the process would be for 
introducing changes to the ethics programs in the two agencies.  Additional goals of the key 
informant interviews were to access information about the agencies’ ethics activities and 
programs not readily available through a search of publicly available documents and to learn 
about the history of the code from those instrumental in developing and disseminating it.  The 
objectives of the document review were to address the first key question, namely to provide an 
overview of ethics activities and programs conducted at the CDC and NIH and to determine to 
what extent they address the 12 principles in the public health code of ethics.  
 
Section I: Key Informant Interview Findings 
Description of Sources 
Key informants interviewed for this study fall into three categories: officials and others 
associated with the ethics programs at CDC, ethics officials at NIH, and individuals with 
knowledge and experience in the development and dissemination of the code of ethics.  In some 
cases an individual fell into more than one category, such as an agency official who was also 
instrumental in the development of the code.  Interviewees and their roles with the agency ethics 
program or code of ethics development included: 
• A CDC public health ethics coordinator and chair of the CDC Public Health Ethics 
Committee composed of representatives from each of the agency’s centers and a variety 
of other offices and special workgroups.  This individual also serves as the designated 
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federal official for the Ethics Subcommittee of the Advisory Committee to the Director, 
which is a group of external advisors who provide input to CDC on a broad range of 
public health ethics issues.   
• A CDC official who oversaw public health ethics activity at CDC, specifically the 
implementation of the activities related to the agency’s internal public health ethics 
program and the external public health ethics advisory committee. This individual is also 
active in the agency’s public health ethics education activities in addition to some work 
specifically on research and human subjects ethics. 
• A university professor who serves as a member of the CDC’s external public health 
ethics advisory committee, serves as co-chair of the Public Health Leadership Society’s 
Ethics Committee, oversees her school’s Public Health Program, and has a long history 
of working on the Code of Ethics from its development to current efforts to disseminate it 
via speaking engagements and on-line seminars.  
• The Acting Chief of the NIH’s Department of Bioethics and head of the Section of 
Human Subjects research.  This individual is based in the NIH’s Clinical Center and also 
works in the Intramural Research Program at NIH. 
• An NIH intramural investigator and administrator within the Human Genome Institute 
involved with issues related to ethics, conflicts of interest, and compliance with rules 
regarding human subjects.  This individual’s research is related to the translation of new 
genomic information to the clinical setting and into public health settings.  In addition, 
this individual serves as an adviser to the institute director on societal implications of 
genomics, including policy matters and how genomics is being used both in a research 
setting as well as its translation to clinical use as well as the society more generally.  
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• An NIH attorney who has been working in the area of Federal government ethics for 
close to two decades.  This individual served as an attorney in the General Counsel’s 
Office in the Ethics Division at NIH which coordinates 31 different ethics offices across 
the NIH campus.  This individual now serves as the Senior Policy Officer in the NIH 
Ethics Office, setting policy and coordinating training for NIH employees and ethics 
officials.   
• The Senior NIH Ethics Counsel, an attorney in the Department of Health and Human 
Services Office of the General Counsel’s Ethics Division who advises those who are 
coordinating government ethics programs and oversees how the ethics program is being 
implemented. 
• Co-chair of the Ethics Committee for the Public Health Leadership Society who has 
worked on the development of the code as well as its dissemination through speaking 
engagements, on-line seminars, and work with local, state, and federal agencies to 
encourage them to consider the code of ethics in their work. 
• A member of the Public Health Leadership Institute Board at the time of the code’s 
development and current Health Commissioner of his county’s health department. 
Key findings 
Key Question 1: In the context of the 12 principles of the public health code of ethics, what are 
the current practices of the CDC and the NIH, the two largest federal public health agencies?    
Key finding 1.1:  Information collected from key informants affirmed that CDC and NIH 
have ethics programs and activities that address all or most of the 12 elements of the public 
health code of ethics 
The key informants interviewed for this study commented on the extent to which the mission and 
work of their agencies aligned with the principles that make up the public health code of ethics.  
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Information from the interviews revealed that both agencies have ethics programs and activities 
in place that address most or all of the 12 principles found in the code.  In addition, there was 
general agreement among CDC and NIH officials interviewed for this study that the missions of 
both align well with the code’s principles and/or are addressed by current activities within the 
agencies (see Table 6).  
Table 6: Specific Mentions by Key Informants of the 12 Principles from the Public 
Health Code of Ethics as Having Alignment with Agency Mission or Programs  
Principle from Code of Ethics (summarized) CDC NIH Potential gap? 
1) address fundamental causes of disease and 
requirements for health, prevent adverse health 
outcomes 
? ? no 
2) achieve community health in a way that 
respects the rights of individuals in the 
community 
? ? no 
3) ensure an opportunity for input from 
community members 
? ? no 
4) empowerment of disenfranchised community 
members 
? ? no 
5) implement effective policies and programs that 
protect and promote health 
? X Yes for NIH 
6) obtain the community’s consent for their 
implementation 
? ? no 
7) act in a timely manner on the information they 
have  
? ? no 
8) incorporate a variety of approaches that 
anticipate and respect diverse values, beliefs, and 
cultures in the community 
? ? no 
9) enhance the physical and social environment 
 
? X Yes for NIH 
10) protect the confidentiality of information that 
can bring harm to an individual or community  
? ? no 
11) ensure the professional competence of 
employees 
? ? no 
12) engage in collaborations and affiliations in 
ways that build the public’s trust and the 
institution’s effectiveness 
? ? no 
Note: a check mark indicates that at least one key informant mentioned at least one program or policy specifically addressing the 
principle.   An “X” entry indicates both that no interviewee offered examples of alignment with agency work and at least one key 
informant expressly noted that the principle falls outside of the agency’s mission or the agency does not have policies or 
programs to address it.  
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This section will expand on the summary in Table 6 to report findings first from CDC officials, 
then from NIH officials including their opinions on how well the principles align with their 
respective agencies’ missions and specific programs they mentioned that address the principles.  
Subfinding 1.1.a: CDC officials described programs and activities that address all of the 
principles in the code of ethics 
When asked whether any of the principles stand out as concepts that although aligned with the 
agency’s mission, are not addressed by current ethics programs, A CDC official responded that, 
“I would say they all align with our work.” Another said, “I think it’s a gestalt of the list of the 
12 of them that resonates with us,” noting that while there may be some in the agency who 
would argue that the phrasing of the principles could be tweaked or improved, the concepts 
represented within them are sound and align with the mission and work at CDC.  Officials 
further noted that there are several programs that relate to specific principles, and others that 
seem to be more infused into the culture and all the work that CDC does.  For example, 
regarding the fourth principle—“public health should advocate and work for the empowerment 
of disenfranchised community members, aiming to ensure that the basic resources and conditions 
necessary for health are accessible for all”— the agency has a program called Racial and Ethnic 
Approaches to Community Health, or “REACH” within its Chronic Disease Center that aims to 
empower disenfranchised communities and a program in the Agency for Toxic Substances and 
Disease Registry (ATSDR)  that works with tribal communities that serve as examples of ways 
this principle is addressed by current programs.  More broadly, the official noted that concepts 
expressed in the first principle—“public health should address principally the fundamental 
causes of disease and requirements for health, aiming to prevent adverse health outcomes”—are 
not captured in a single program, but rather are an integral part of the agency’s mission that 
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permeates all the agency’s work saying, “Clearly, everything we do here is about the importance 
of science underlying decision-making and is in place at all CDC's programs.”   Similarly, 
regarding the tenth and eleventh principles—“public health should protect the confidentiality of 
information…” and “public health institutions should ensure the professional competence of 
their employees”— the official noted that “There's the emphasis on confidentiality of 
information for all programs.  There's a privacy officer and a confidentiality officer here.  And 
then in terms of professional competence, there's a whole group that just deals with workforce 
development issues.”  Other ways the agency addresses the professional competence of its 
workforce is through several fellowships for developing public health professionals such as the 
Epidemic Intelligence Service which this official described as “a two-year fellowship for training 
public health professionals… sort of an on-the-job training” and a fellowship in public health 
ethics through Tuskegee University.   
The extent to which the public health code of ethics aligns with CDC’s work is underscored by 
the fact that there are efforts underway in the agency to disseminate the code and to evaluate its 
employees’ awareness of its principles.  Part of the agency’s public health ethics activity has 
been dedicated to workforce education and development in two ways that highlight the code of 
ethics.  First, the ethics office has fielded a first-of-its-kind CDC-wide survey to determine its 
workforce’s awareness about the public health ethics activities at CDC as well as its awareness 
about public health ethics in general.  The survey includes a question specifically about the 
public health code of ethics.  The goals of the survey were to get a sense of how many within the 
CDC workforce know about the topic of public health ethics and about the code itself.  The 
survey was being fielded at the time the interviews were conducted for this study.  CDC officials 
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expect results to be reported at the APHA conference in November 2010.  Preliminary results 
were not available at the time this study was conducted. 
A second effort is the agency’s public health ethics online training which was a year in 
development and includes a section devoted to the public health code of ethics.  That section 
includes a listing of the code’s principles, a module on its contents, and a self-assessment with 
specific questions about the users’ knowledge regarding the code’s principles.  CDC officials 
said that the training is now available to all CDC employees, contractors, and others, and is part 
of an effort to disseminate the code and “to really help put these things out in front of folks.”  
The agency also offers other ethics training opportunities to its staff including an annual lecture 
from an outside speaker who talks about some key issues regarding public health ethics.  In 
addition, the agency offers a quarterly training opportunity for staff wherein the agency 
collaborates with the Emory University School of Public Health Center for Ethics to bring a 
guest speaker or trainer to discuss or lead a group discussion of topics in public health ethics.   
According to agency officials, in formal and informal ways, the leadership at CDC is using the 
code of ethics and seeks to raise awareness about it among the public health workforce.  One 
official noted that CDC’s ethics leaders try to highlight the code of ethics in the course of their 
own professional interactions, providing several examples from personal experience:  
“Whenever I do talks, I always bring along a copy of the code of ethics and I refer to it.  
Often, I will ask CDC staff, how many of you know that there is a code of ethics out 
there?  And actually, in the beginning, not that many people knew but I think more and 
more, as I do more talks, more people are aware that it exists.  Of course, we have links 
to it on our website.  So we are trying to make sure people are aware of it and we refer to 
it, and we see it as a good documentation of the values in public health and some of these 
guiding principles.  But we're not viewing it as our one and only code of ethics.” 
Another way this is happening is through a collaboration with colleagues outside of the agency 
who serve on CDC committees or are otherwise associated with the agency to infuse the code of 
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ethics into presentations and partnerships for state and local public health workers.  Specifically, 
CDC is working with a member of its Ethics Advisory Committee and others to host a seminar 
with the goal of identifying ways state health departments can implement the code.  In summary, 
one CDC official noted that regarding public health ethics training for staff and external partners, 
“there are a variety of things that we offer and that people take advantage of.”  The key 
informants from CDC indicated that the principles in the code of ethics are integrated to a high 
degree into the agency’s training and other education offered to the CDC workforce and others in 
the field of public health, illustrating their point that the principles align strongly with the 
agency’s mission. 
Subfinding 1.1.b:  NIH officials described programs and activities that address ten of the 
principles in the code of ethics 
The NIH officials interviewed for this study also indicated that the principles within the code  
generally aligned well with the mission of the agency, but noted some exceptions.  One key 
informant stated that, “I think that individually, many of the principles actually align very well 
with what we do.”  However, the official also raised the issue that some of the principles relate 
specifically to the implementation of public health programs which the official believes does not 
necessarily align with NIH’s mission, stating, “that's not what the NIH is supposed to do— 
implement programs.”  The official pointed specifically to the fifth and ninth principles—“public 
health should seek the information needed to implement effective policies and programs that 
protect and promote health” and “public health programs and policies should be implemented in 
a manner that most enhances the physical and social environment” – as principles perhaps not in 
alignment with the core work at the agency, saying, “ I guess both of those speak to 
implementation in a way that doesn't seem to make sense in terms of how I understand what the 
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NIH does.”  These comments point to a key difference between the CDC and NIH in that 
although there are important public health programs coordinated by the NIH, the NIH’s ethics 
programs are much more focused on biomedical ethics and the protection of human subjects 
given the agency’s mission as a research institute, while the CDC has dedicated resources to and 
recognizes public health ethics as an important part of its overall ethics program.   
Despite this difference, NIH officials affirmed that most of the code’s principles are addressed in 
some way by the agency’s ethics activities and programs.  Typically, they described the concepts 
within the code as in alignment with the way NIH does its work, whether defined as “public 
health” or biomedical research.  For example, one NIH ethics official recognized general 
alignment of NIH’s mission with several of the principles stating: 
 “I think for the most part, number one is addressing fundamental causes of diseases.  
That's really what the NIH mission is supposed to be about in terms of its research.  The 
second one is respecting the rights of individuals in the community ... That's certainly 
what the NIH is about.  The third one is about community input and there are lots of ways 
that the NIH goes about getting community input on a regular basis …  The fourth one is 
about advocating for the empowerment of disenfranchised communities.  That's a little 
less directly what NIH does but certainly there's a large emphasis on research to reduce 
health disparities…  The sixth one is about providing information.  NIH has a large role 
in providing information to the general public about research and health.  The seventh 
one is about acting in a timely manner on the information they have, so certainly, any 
time there's a research result that the NIH is responsible for in some way, it has a moral 
responsibility to get that out to the public and, I think, takes that responsibility very 
seriously.  Incorporating a variety of approaches that anticipate and respect diverse 
values, beliefs and cultures in the community -- I do think that the way we go about 
engaging communities and the way we go about deciding research priorities and the way 
we go about conducting research all sort of takes that into account.  Confidentiality - 
that's a big thing that everybody pays attention to.  Professional competence - that's again 
something that as an institution, I think, we do pretty well.  And how we engage in 
collaboration and affiliation, these are things that the NIH does pay attention to.”   
Another NIH official highlighted the agency’s work to ensure that “all communities have a 
voice,” underscoring that public health has a particular interest in underserved or marginalized 
communities—the concept addressed by the code’s fourth principle.  Coupling that idea with the 
twelfth principle—“public health institutions and their employees should engage in 
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collaborations and affiliations in ways that build the public’s trust and the institution’s 
effectiveness”—this and other officials at NIH  recognized the importance of building and 
maintaining the public’s trust in the way the agency uses the taxpayers’ money to carry out its 
mission.  Specifically, this official sees the role of being good stewards of the public’s money 
and service to the underserved as intertwined and relevant to the agency’s work noting, “How we 
use the $30 billion plus that NIH receives is actually impacting communities, is not just 
impacting technology, but [serving] those that may be underserved or marginalized.  So I think 
that clearly, the statements [principles] here are relevant and have importance for the work of 
NIH.”  Officials emphasized the agency’s efforts to assess and minimize conflict of interest 
among its staff and grantees as an example of how it addresses the twelfth principle in the code.  
Specifically, one key informant noted,  
“I think we run our standard of conduct rules so that the public health institution, the 
NIH, and their employees engage in all of their official duties in ways that build the 
public’s trust, not just collaborations and affiliations.  And that it maintains the 
institution’s effectiveness in the sense that nobody would question our results, that 
everybody who reads the results of NIH research would say, ‘That’s always done to the 
public’s advantage,’ that the public’s health is always put first and foremost in all the 
research that we’re conducting.  So I do think we administer our programs very much so 
consistent with [principle] number 12.” 
This official further noted that leaders within the agency frequently talk about the ways in which 
they can avoid putting the public’s trust in NIH at risk and consider a rigorous enforcement of 
the standards for ethical conduct, including conflict of interest guidelines as an important tool in 
doing so. For example, one official said that a “reasonable person could lose trust in the NIH 
programs if he or she thinks that the programs are being administered in a way that the public’s 
health is not first and foremost.”  Finally, officials mentioned the agency’s Council of Public 
Representatives (COPR) as a program that addresses the third principle—“public health policies, 
programs, and priorities should be developed and evaluated through processes that ensure an 
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opportunity for input from community members.”  The COPR is comprised of members of the 
public and advocates for people living with diseases and conditions studied by NIH and serves in 
an advisory role to the NIH Director, ensuring that there is community input into the agencies 
program and funding decisions.  In addition, one interviewee cited the requirement that federal 
agencies provide public notice and opportunity for comment for certain program decisions as an 
additional means of addressing this principle. 
In general, officials from both agencies indicated that the code’s principles align closely with the 
agencies’ missions and work.  Exceptions to this were from NIH officials who did not readily 
identify programs or activities to address or mission alignment with two of the principles.  
Specifically, officials did not offer examples of current programs or activities addressing the fifth 
principle—“Public health should seek the information needed to implement effective policies 
and programs that protect and promote health.” Similarly, they did not recognize alignment with 
their agency’s mission and the ninth principle—“Public health programs and policies should be 
implemented in a manner that most enhances the physical and social environment.”  While they 
acknowledged that NIH-funded research results may indeed be used to address these principles, 
the focus on implementation of programs did not seem to fit with the agency’s primary focus on 
basic research.  While the agency officials interviewed for this study do see general alignment 
for the code’s principles, they have also raised some question about the value of the code to an 
agency whose mission is predominantly focused on biomedical research, a topic discussed in 
greater detail in later findings of this study.  One NIH official expressed that although the code’s 
principles are important and in many ways related to the agency’s work, if the code were to be 
used at NIH, the principles may have to be reframed to fit more directly in an environment where 
research, as opposed to implementation of public health programs is the focus.  
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Key Question 2: To what extent has the public health code of ethics been given specific 
consideration by the two largest federal public health institutions?  
Key finding 2.1: Familiarity with the public health code of ethics varied dramatically 
between agencies: All CDC officials and associates interviewed for this study were familiar 
with the public health code of ethics, and none of the NIH officials had seen or heard of the 
code before being interviewed for this study 
 
Of the CDC officials and associates interviewed for this study, all of them were familiar with 
the public health code of ethics and had used it in the course of their work with the agency.  One 
interviewee who chairs the CDC Public Health Ethics Committee noted that the code was used 
in the agency’s discussion paper on public health ethics as a tool to articulate the ethical 
foundation for the practice of public health.  Another official had worked with the code  as the 
CDC developed ethical guidances on the topics of collection, storage, and use of data not only 
for its staff, but also for its grantees and other external partners saying,  
“we made use of this set of principles as we were developing and thinking about how we 
would operationalize some of the tasks that we needed to put into very specific guidance 
for our partners, not just our internal scientists and public health practitioners but also 
folks with whom we work out in the states.  So this set of principles as well as the rest of 
the work of the Public Health Leadership Society was extremely helpful for us in terms 
of having some context and some background for us to kind of ground how we were 
going to operationalize some of the principles for our partners.”   
In addition to those who reported using the code in their work, some officials at CDC had been 
involved in the development of the code or were a part of the agency’s conversation about 
whether to formally adopt or endorse it, discussed in detail in the next finding. 
In stark contrast to the CDC officials’ familiarity with the code, none of the NIH officials 
interviewed had heard of the code prior to being interviewed for this study.  One official noted 
that despite being a member of the APHA, the official had not been familiar with the code, but 
did not think that was particularly unusual.  The key informant drew a parallel with a set of 
guidelines developed for core competencies in the field of gemonics developed by APHA, saying 
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that these competencies have also not been disseminated widely and therefore not necessarily 
known to those in the field.  The official noted,  
“I think this is not an uncommon thing to happen, but sometimes, within the governance 
structure of an association as large as APHA, principles or guidelines or declarations are 
made through the governance process but are not disseminated in a broad way… I do 
think that there is information here in some of the principles that clearly could be of value 
to the government, both CDC and NIH, with regards to the framing of public health 
issues and ethical principles.” 
Despite the fact that all of the NIH officials interviewed for this study were involved in ethics 
programs and activities at the agency, none had familiarity with the code.  As a result, they were 
also unaware of any effort to or discussion about the agency adopting it formally or using it in 
any way within its ethics programs.  Because the key informants from NIH are senior leaders 
involved in the agency’s ethics programs, they are in a position to know whether such a 
discussion were underway at the agency.   Therefore, for the purpose of this study, we will 
conclude that NIH has not considered formal adoption of the code.   
When asked whether the code would be a useful tool for the agency, NIH officials responded 
with mixed opinions.  One official indicated that there might be a potential benefit to using it to 
“help keep everyone’s focus and to serve as a good reminder that we’re a public health agency 
and not an academic institution.”  Another noted that “no one could argue with any of these 
principles that they are all important.  I think you can reframe them to fit into a research 
environment of NIH.”  When asked whether the code might add any benefit to the agency’s 
ethics program, one official responded, “I guess I would address it much more on where are the 
problems and what is needed from a regulatory perspective to address those problems to enhance 
the practice within the field of biomedical research and the ethical practice.  So it’s less about 
creating a set of principles and it’s more about what do we really need to do from an applied 
perspective to make sure that actually, those types of principles are being implemented in an 
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appropriate way?”  While none of the key informants doubted that the principles were sound and 
were generally relevant to the agency’s work, there was no consensus on whether the code would 
be a useful tool in a formal or informal way. 
 
Key finding 2.2: The CDC has considered formally adopting the code and has declined to 
do so 
 
CDC officials said that there had been discussions in the agency about whether to formally adopt 
the public health code of ethics which resulted in a decision not to do so.  One official described 
internal disagreement over whether formal adoption of the code would be necessary or beneficial 
given that many view the code as one tool among many to use in articulating the agency’s view 
on public health ethics.  The official noted that, “I think that there's dispute over whether that 
would be a good thing or not because I think our approach is that we view the code… as 
something that is useful but we don't really think it's useful to say this is the one code that we 
will live by.  So instead, we want to see it as a tool along with other types of tools that could be 
useful.”   
Another agency official described the decision not to formally adopt the code as less a deliberate 
rejection of the idea and more of a case of the issue being debated, but just not resolved, resulting 
in the agency not taking action to adopt the code.  The key informant noted that a small group of 
the CDC leadership team discussed the matter on more than one occasion, specifically talking 
about what it would mean for the agency to make a formal endorsement or adoption of the code 
and specifically what the legal implications would be for such an action.  “These discussions 
went on with a small group of people within the agency and it just ended up not getting to the 
priority level to solve.  It never came to resolution whether we would or would not.  There was 
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no compelling reason to or not to formally endorse [the code].”  The official went on to describe 
the fact that whether the code is formally adopted by the agency may not matter in terms of its 
use and its relevance to the agency’s work.  Because a number of CDC officials who currently 
work in the area of ethics had involvement in the code’s development, this official said their 
support of the principles it contains can be assumed.  In addition, since many have worked with 
or are members of the organizations that developed or adopted the code, for many staff members, 
acceptance of the principles has occurred outside of the agency.  One official stated that,  
“Most of the people who work in public health and who work at CDC are involved with 
APHA and many of us have done work with the Public Health Leadership Society.  Many 
of us already have adopted these principles and these ethical values, as part of our 
membership in these other organizations. It didn’t seem compelling or absolutely 
necessary for us to make any statement on adopting these specifically for CDC.  In 
addition to that, our work with developing them, in many ways I think, sent signals about 
our belief in what they stood for.” 
Within the CDC, while there appears to be wide acceptance of the code and agreement that its 
principles are relevant to the agency’s work, there is resistance to formally adopting it.  One 
interviewee described this by noting, “I think that there is acceptance that it is a useful tool for 
our work but I think people stopped short of saying… that this is the one code that we all live by.  
I think people will probably find that too limiting.”  Resistance to formally adopting the code 
may exist in part because the principles align so closely to the mission and work of the agency 
and because so many of the ethics officials were involved in the code’s development or have 
accepted the code professionally through other organizations like the APHA that have adopted it.  
One official recognized this, saying, “It’s something that is so ubiquitous around our work that 
there’s hardly any reason to formally do anything about that.  And there were so many people 
already involved with this kind of work, [who] have membership groups that have adopted this 
as their ethical mantra, that perhaps most of us already see this as part of the way we function.” 
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Although CDC has not formally adopted the code, it features prominently in the discussion paper 
which serves as the agency’s framework for public health ethics .(CDC Public Health Ethics 
Committee, 2007)  In addition, agency officials noted that CDC uses the code as a basis for web-
based training it is developing for agency staff to provide a foundation and common 
understanding about what public health ethics is and how it applies to the practice of public 
health.  One official noted that, “there is a module that deals with the values in public health and 
then another module that deals with the ethical principles and that's really coming from the 
document, Principles of Ethical Practice of Public Health.”   
 
Key finding 2.3: Officials at both agencies identified potential barriers to adopting the code 
leading to mixed opinions about the benefit of doing so 
 
Officials from CDC and NIH identified several barriers to using the public health code of ethics 
in their agencies.  In general, these barriers fell into two broad categories: 1) legal issues and 
agency authority and 2) justifying the need for the code.  Within these categories, in some cases, 
officials from both agencies identified similar barriers, while in other cases, those from NIH 
raised issues unique to their agency. 
Subfinding 2.3.a: CDC and NIH officials identified legal obligation and agency authority as 
barriers to adopting the code. 
Key informants from both agencies discussed the issue of legal obligation and agency authority 
as potential barriers to formally adopting a code of ethics for an agency.  One CDC official noted 
that the leadership group that convened to discuss the possibility of formalizing the code at CDC 
specifically discussed the legal obligations that may come with adopting or endorsing a 
particular code of ethics.  While the group did not resolve this issue, it raised the question of 
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what the agency’s legal obligation would be to enforce the code if it was adopted.  In other 
words, it asked what consequences the agency would bring to bear in the event that an employee 
did not act in accordance with the code when carrying out the agency’s work.  One official 
offered an example, asking, “What is our responsibility to enforce number 11 [the principle 
regarding ensuring professional competence].  What if one of our employees does something that 
proves or shows they’re professionally not competent, what is our legal responsibility then?”  
She used this example to highlight that questions of accountability and enforcement would have 
to be resolved before the agency could consider formally adopting the code.  In addition, she 
noted that consideration would have to be given to whether the agency would be obligated, or 
choose to, enforce these principles with its contractors, grantees, and other partners it engages for 
public health activities.  The agency conducts only a portion of its public health mission through 
its employees. A major portion of its budget goes to funding public health work through 
grantees, contractors, and other entities it funds to carry out the agency’s mission. Would 
adopting the code mean enforcing it among CDC employees and all of the agency’s funded 
entities?  Does the agency have the legal authority to do so?  The leadership group at CDC 
acknowledged that it raised but did not resolve these important questions.  Agency officials 
noted that if the issue of formally adopting the code is to be revisited, these questions would have 
to be addressed and a means of enforcement would have to be put in place.  
Key informants at NIH raised similar questions about authority and legal considerations when 
asked about barriers to formally adopting the code, but made a distinction between accepting 
aspirations within a code of ethics and translating them into policy.  One official at the agency 
put it this way, “the problem is not so much in terms of [the code’s] aspirations.  The problem 
could be related to proposed implementation of programs or activities to achieve those 
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aspirations.”  The official used the agency’s assessment of conflict of interest to illustrate the 
point.  The Standards of Ethical Conduct that apply to all federal employees include provisions 
regarding employees’ conflict of interest.  As a result, the agency has put into place a system and 
policies for meeting its obligation to assess and address conflict of interest among its employees, 
including requirements for employees to disclose certain financial information. The official notes 
that,  
“Part of the way we address conflicts of interest is through the financial disclosure 
system.  But the financial disclosure system is described for us by regulation and we 
cannot ask our employees for and collect from them information about their financial and 
other relationships that goes beyond that which we are permitted to request under the 
regulation.  So that if there were found to be concerns that we were missing something or 
we weren’t asking a question that would get at some other information of value, we could 
not independently just start doing so.  We have to go to a regulatory or statutory process 
in order to gain permission to do so.”   
This example points to the fact that acceptance of the code’s principles is one thing, but to 
formalize it in a way that required employees to follow it, may require the agency to seek 
additional legal authority to enforce it.  According to one key informant, “The devil is always in 
the details of how we are able to say objectively we’re achieving this goal—or to develop a 
measure against which we can say ‘No, we’re not.’”  Obtaining the authority to enforce the 
principles of the code is an activity outside of the agency’s control and would need to be 
considered before it could adopt a set of principles such as those found in the public health code 
of ethics. 
Subfinding 2.3.b: CDC and NIH officials recognized the lack of a clearly articulated 
rationale for the code as a barrier to its adoption. 
Officials at both agencies discussed the importance of articulating a clear rationale for using the 
code.  They agreed that the absence of a clear and convincing justification for the code would be 
a significant barrier to having it used in the agency.  In general, the comments from key 
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informants indicated that no matter how well-intentioned the code’s creators are and how 
agreeable the basic principles are, without providing specific rationale for how it can improve an 
agency’s programs and quality of work, it will not be successfully adopted or used at CDC or 
NIH.  One CDC official who thinks the code would be useful to the agency said,  
“we need to really be able to demonstrate to people that what we're trying to do on public 
health ethics can make a change in our programs.  I think some people, if you can't sort of 
objectively identify what your impact is then they may be a little hesitant wanting to 
adopt what you're talking about.”  
In contrast to this official’s implied advocacy for the code’s use at CDC, an official from NIH 
was not convinced of the need for the code.  Despite finding the principles reasonable, this 
official is unclear about how using the code would improve the work of NIH saying, “the 
principles that are enunciated on this list of twelve— there's nothing about any of them that I 
would say is objectionable or wouldn't be useful in some way, but I don't know that having this 
particular list of twelve would make any difference in terms of the way people do things.”  The 
key informant noted that although several of the principles are directly related to the work at 
NIH, the value of endorsing a code of ethics for public health is not obvious.  Specifically, the 
official notes of several of the topics addressed in the code, “these are things that the NIH 
basically does pay attention to.  Whether or not it would help them to have this list of 12 in front 
of them?  It's hard to see that it would make much difference, I have to say.”   
Another NIH ethics official expressed a slightly different opinion about the value of committing 
to a set of principles to guide expectations about employees’ work and ethical practice, noting “I 
always think that’s it’s extremely important for there to be dialogue and conversation about what 
is expected and having framing principles is extremely important.”  When asked specifically 
about the value of the public health code of ethics to the agency, the official was not certain, and 
echoed concerns from other key informants about the agency’s authority to enforce a particular 
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set of principles saying, “If [the code] is to be used as principles to help to frame boundaries and 
how an agency or an individual does work, then ultimately they must get transferred into actual 
rules and regulations.  And so my question would be what are we trying to solve and what is the 
issue at NIH that we would be seeking to solve and does this set of principles actually do that or 
is there something that is framed in a different way that would be valuable?”  This comment 
raises questions about whether the code is directly relevant to the workforce at NIH and whether 
it would fill a void in current ethics programs and policy.  
Several of the key informants from NIH questioned whether NIH was really a “public health 
agency.”  Although the agency falls within the federal government’s Public Health Service, NIH 
officials more readily identified the work of CDC and others within the U.S Public Health 
Service as more directly related and devoted to traditional “public health” work than NIH which 
they consider more focused on basic biological research and discovery.  One official noted that 
although there is general alignment of the public health code of ethics with NIH’s work, the 
collected set of principles may not have a place in the agency given the focus on program 
implementation rather than research saying,  
“The National Institutes of Health’s mission is to discover new information that will help 
to reduce the burden of disease and improve health so clearly, the issue of the public 
impact is important to the work of NIH.  But in reality, we are not a public health agency 
from what I would consider a traditional public health agency.  I clearly think that CDC 
has that role and even HRSA (Health Resources and Services Administration) has some 
of that role within the federal government and really NIH’s primary mission is the 
discovery of new knowledge to help to improve the health and reduce the burden of 
disease.  But one of the questions whenever you look at a grant application or a new 
protocol is, what is the public health impact described in the work that they’re doing?” 
All of the NIH officials interviewed for this study acknowledged that there is public health work 
that results from the research at NIH, but in terms of the culture and the way workers within that 
agency view their mission, many of them questioned the accuracy of calling the agency a “public 
health agency,” and by extension, questioned the value of adopting a code of ethics for public 
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health at an institution that does not necessarily see itself as an agency with public health at the 
core of its mission and purpose.  
 
Key Question 3: If benefits are identified, how can specific barriers to implementing the code of 
ethics be addressed to fill gaps in the agencies’ current ethics programs? 
Key Finding 3.1: The CDC and NIH each has a process for considering additions or 
changes to agency ethics programs which would allow gaps in their programs to be 
addressed 
 
Interviews with CDC and NIH officials revealed that both agencies have clearly defined 
procedures for considering changes to their respective ethics programs and policies.  Key 
informants were asked to describe their agency’s process for making changes to their ethics 
policies and who the decision-makers are when new information or resources are presented for 
consideration.  Both agencies have multiple levels of ethics rules to which their employees are 
accountable, including rules at the federal, department, and agency levels.  In addition, key 
informants from both agencies described multi-pronged approaches to training employees 
regarding ethics rules and several channels through which employees can learn about and seek 
support for ethical dilemmas or questions that arise during the course of their work. 
CDC: Process for change 
CDC officials interviewed for this study noted that following the agency’s re-organization under 
former CDC Director, Dr. Julie Gerberding, and the subsequent appointment of Dr. Thomas 
Frieden as Director in 2009, the decision-making for high level policy changes such as to the 
ethics program has changed.  At the time the agency was considering adopting the code, there 
were three groups involved in the discussion and decision-making: the Executive Leadership 
Board, the Scientific and Center Leadership group, and the Business and Management 
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Leadership group.  First, the Executive Leadership Board consisted of the scientific and 
management executive leaders at CDC, all of whom reported to the Director’s Office and ran the 
executive decision-making of the agency.  Next, the Scientific and Center Leadership group was 
comprised of scientific leaders at the agency who ran and were responsible for the center-specific 
subject matter for what were at the time twelve centers within the agency with anywhere from a 
few hundred to a few thousand people and scientists and program people within their purview.  
The twelve Center Directors formed this group which had some decision-making power in the 
area of ethics policy.  Finally, the Business and Management Leadership group was made up of 
representatives from each Center with expertise in the administrative aspects of the Centers.   
Collectively, these three groups would, in some combination, discuss and make decisions about 
high-level issues such as policy changes for the agency’s ethics programs.  One official noted 
that “ often these groups would consult other groups whether they were scientific leaders or other 
kinds of leaders that were deeper in the organization about specific issues, but ultimately, that 
kind of CDC endorsement [of the public health code of ethics] would come from a decision 
made from these three leadership groups.”  Further, the official added, “It’s interesting because 
when we first talked about whether we would adopt this, we were under the leadership of our 
previous [Director] and our previous organizational structure.  We have recently had a new 
agency director appointed and that agency director has re-organized the Office of the Director of 
the agency and now new structures are in place in terms of who makes what kind of decisions.”  
This key informant acknowledged that at the time this issue was debated, the new decision-
making structures put into place by the Director “were not operating to full speed yet.”  So, if the 
issue had been put up for a final decision, it would have been considered under the process 
described earlier, through the three decision-making bodies at CDC.   
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When asked about the current process, if the decision to adopt the code should come up again for 
consideration, officials noted that it would likely be decided in a more centralized manner within 
the Office of the Director of CDC, but with input from the same groups of leaders.  One official 
explained it like this:  
“Now, things are different and a decision like this would likely be made through the 
director with some advice from his immediate leadership team which consists mostly of 
the directors from the centers and his close leadership team which includes a group of 
people who are deputy directors for program and science and policy and his associate 
directors on those topics as well.  So it’s a similar kind of structure.  They’re called 
different things but ultimately it’s the same level of leadership that would make this kind 
of decision.” 
The official noted, however, that under the agency’s new leadership, the issue of adopting the 
code has not emerged as a priority as it had been under the previous Director.  One agency 
official stated that “With our old director, this was something that very much was setting the 
stage and being sure that we had a lot of visibility and leadership around, public health ethics 
was very important and we definitely… these issues were very much on the radar screen and 
extremely visible.” In contract, the official noted that currently it has not been a priority and is 
not an issue that has been brought back to the table for re-consideration. 
 
NIH: Process for change 
NIH officials interviewed for this study provided insights into the process by which changes to 
the ethics policies or programs would occur at the agency and any barriers that might exist to 
making such changes.  Because the agency does not make a distinction in its ethics programs 
between research ethics and public health ethics as the CDC does, the process for change 
specifically regarding public health ethical principles is not entirely clear.  However, a discussion 
of policy review and change in general for NIH could serve as a guide to understanding or 
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approaching changes one might propose for public health ethics.  The descriptions of the process 
for introducing a change varied across NIH officials interviewed for this study and are 
summarized in this section. 
One official described what the process would be for changing agency-level policies regarding 
ethics saying that “I guess the starting point would most likely be in the NIH Ethics Office and 
then I’d raise it internally to the deputy director for policy and procedure.”  This official gave an 
example of a change to ethics rules that followed that path when agency leadership felt it was 
appropriate to create a more rigorous ethics training requirement for staff than what was 
mandated by law.  Whereas there was a regulation stating that only certain staff had to be trained 
annually in ethics procedures—which amounted to approximately half of the NIH workforce—
the agency leadership believed that all staff should receive annual training.  As a result, the 
agency created its current policy that all staff are trained annually in ethics procedures.  That 
policy came about because the agency determined that it wanted to put into place a more 
stringent policy than what the regulations required.  This official said that the agency is at liberty 
to change ethics policy if, at a minimum, the regulations governing ethics are satisfied, further 
noting that “the government-wide rules are the floor, so any policy we would put out would have 
to be raising the bar.”  This key informant said that there is a flow of feedback from the institutes 
and centers to the central NIH Ethics Office that can and does result in policy changes.  The 
official noted that because the office meets regularly with the Ethics Officers from each institute 
and center, “they’re constantly giving feedback on how they feel procedures and policies are 
working and we take that very much to heart and we’re revising our policies all the time to try to 
reflect often the very great input that we get from them.” 
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Another official explained that for policies that are related to the ethical practice of research, the 
Office of the Director of Intramural Research would have authority to consider and implement 
changes for the agency. Within that office, the NIH Scientific Integrity and Ethics Committee is 
responsible for scientific conduct and misconduct and scientific integrity among intramural staff.  
The official explained that in addition, the Committee “oversees, in a general way, the conduct 
and research courses that every branch, every laboratory is required to have.” Then, at the 
institute level, every institute has an ethics officer and some have an ethics office both of which 
are tasked with monitoring and supporting employees’ compliance with the federal standards for 
ethical conduct or, as one official described it “what the employees at their institute can and can't 
do.”  They oversee how agency employees do research and whether they follow the ethics 
guidelines that are laid out in the regulations.  In addition, there is the Office of Extramural 
Research which ensures that all extramural researchers funded by the agency follow the 
regulations and the ethics rules.   
Another official described his understanding of the process for change like this: “My 
interpretation of it is that really, the direction comes from a central level and then it’s kind of 
distributed out to the [institutes and centers], and they may translate that or actually implement it 
in unique ways to their environment.”  This official further noted that within the intramural 
program, there is a governance process where investigators, working with the scientific directors 
in the agency have the ability to offer policy recommendations and raise issues of importance to 
the intramural program for consideration by the agency.  Yet another official indicated that the 
process for change might vary depending on the issue or topic area, noting that  
“I think it would depend on the topic.  If an individual has a suggestion or thoughts about 
how the current ethics program is being managed or implemented, they are usually not 
shy about letting us know and they would go to program officials with their feedback.  If 
an individual has an idea about something that is not addressed at all but they think that it 
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should be, the policymakers might depend, again, on the precise topic because there are 
at times policy decisions have to be made by NIH in consultation with the Department of 
Health and Human Services, and at other times, they can be made just within NIH.”   
In summary, agency officials indicated that there is no single, clearly established process for 
ethics policy change at NIH, but rather multiple routes for receiving feedback and suggestions 
and ultimately for making a policy change. 
 
Section II: Document Review Findings 
Description of sources 
The documentation review for this study began with a search of publicly available information 
and was supplemented by material collected from key informants.  Both CDC and NIH maintain 
extensive web sites containing information on their respective ethics programs.  Of the many 
published documents pertaining to ethics activities and programs at the agencies, there were a 
few that were key to the findings derived for this study.  From the CDC, a discussion paper 
published by the agency’s Public Health Ethics Committee provides an introduction to public 
health ethics, discusses the public health code of ethics as a foundation for public health practice, 
outlines the mission and goals of the agency’s public health ethics activities, provides an 
organizational overview of the agency’s ethics resources, and details the agency’s training and  
consultation for public health ethics(CDC Public Health Ethics Committee, 2007).  The agency’s 
ethics web page also provided details regarding specific ethics policies and training opportunities 
for staff.   From the NIH, the agency’s internal introduction to government ethics outlines the 
principles of ethical conduct, discusses conflicts of interest, provides examples of ethical 
dilemmas and how government ethics rules apply, and identifies agency resources for a variety 
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of ethics questions and issues(National Institutes of Health Ethics Office, 2009).  Also from NIH, 
its web pages on the agency’s Public Trust Initiative and individual institute and center pages 
provided details about programs and activities that relate to the principles in the public health 
code of ethics.  In addition, reports from the GAO and the CRS provided background and 
description of public health service agency organizational structure and ethics activities 
(Congressional Research Service, 2005; U.S. Government Accountability Office, April 30, 2007; 
U.S. Government Accountability Office, September 30, 2008).  
Key Findings 
 
Key Question 1: In the context of the 12 principles of the public health code of ethics, what are 
the current practices of the CDC and the NIH, the two largest federal public health agencies?    
Key finding 1.2:  There are programs at CDC and NIH that address most of the 12 
principles of the public health code of ethics. 
 
Both the CDC and NIH publish extensive resources pertaining to their organizational structure, 
programs, research, and policies on their web sites for the public.  Both agencies make available 
to the public documents that indicate robust ethics programs and activities including offices or 
divisions devoted to the topic of ethics, regular ethics committee meetings, programs designed to 
solicit public input into agency priorities (in the case of NIH), policies regarding protection of 
populations involved in research, and programs designed to communicate and share agency 
research and knowledge with various publics.  A search of each agency’s web site and other 
publicly available documents revealed programs, practices, guidelines, or organizational 
components that address most of the 12 principles in the public health code of ethics.  However, 
in a few instances, the search did not yield information to address or fully address the code’s 
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principles.  A summary of results from this review of documentation is presented in Table 7, 
with a discussion of those findings following. 
Components, Programs, and Policies Addressing the Code of Ethics Principles  
Table 7 provides a summary of the publicly available information regarding the agencies’ 
organizational components, programs, policies, and other activities that address the 12 principles 
in the public health code of ethics.  Each agency maintains a web site with numerous resources 
for the public to access research results, information, and tools funded by taxpayers and created 
in fulfillment of their respective missions.  Several specific components, programs, and policies 
displayed in Table 7 address more than one of the principles.  All components are indicated in 
bold and are defined or described, by agency, in the narrative that follows.  Following the 
discussion of these components, programs, and policies, is a summary of potential gaps between 
agency practice and the code’s principles. 
 
 
 
 
 
 
 
 
 
 
 
65 
 
Table 7: Publicly Available Information on CDC and NIH Components, Programs, and 
Policies Addressing the Public Health Code of Ethics Principles  
Public Health Code of Ethics Principlesa CDC Elements Addressing 
Principles  
NIH Elements 
Addressing Principles  
Potential 
Gaps?  
 
1) Public health should address principally the 
fundamental causes of disease and 
requirements for health, aiming to prevent 
adverse health outcomes 
• Agency mission and goals 
• National Center for Chronic 
Disease Prevention and Health 
Promotion 
• Agency mission and 
goals 
• Office of Disease 
Prevention 
 
 
NO 
2) Public health should achieve community 
health in a way that respects the rights of 
individuals in the community 
• Human Research Protection Office 
• Agency pledge 
• Office of Extramural 
Research: Research w 
Human Subjects 
 
 
NO 
3) Public health policies, programs, and 
priorities should be developed and evaluated 
through processes that ensure an opportunity 
for input from community members 
• None found for agency-wide 
policy or process for obtaining 
community input 
• Council of Public 
Representatives (COPR) 
 
YES for 
CDC  
4) Public health should advocate and work for 
the empowerment of disenfranchised 
community members, aiming to ensure that the 
basic resources and conditions necessary for 
health are accessible to all 
• Office of Minority Health and 
Health Disparities 
• CDC/ATSDR Minority Initiatives 
Coordinating Committee 
• National Center for Chronic 
Disease Prevention and Health 
Promotion 
• Office of Research on 
Women’s Health  
• National institute on 
Minority Health and 
Health Disparities 
 
 
 
NO 
5) Public health should seek the information 
needed to implement effective policies and 
programs that protect and promote health  
• Agency mission and goals 
 
• Agency mission and 
goals 
 
  
NO 
6) Public health institutions should provide 
communities with the information they have 
that is needed for decisions on policies or 
programs and should obtain the community’s 
consent for their implementation 
• HealthComm Key  
• None found for “community 
consent” for implementation 
• Public access to research 
results 
• None found for 
“community consent”  
 
Partial 
for CDC 
&NIH 
7) Public health institutions should act in a 
timely manner on the information they have 
within the resources & mandate given to them 
by the public 
• National Center for Chronic 
Disease Prevention and Health 
Promotion 
• Public access to research 
results 
 
NO 
8) Public health programs and policies should 
incorporate a variety of approaches that 
anticipate and respect diverse values, beliefs, 
and cultures in the community 
• Office of Minority Health and 
Health Disparities 
• CDC/ATSDR Minority Initiatives 
Committee 
• COPR 
• National Institute on 
Minority Health and 
Health Disparities 
 
 
NO 
9) Public health programs and policies should 
be implemented in a manner that most 
enhances the physical and social environment 
• Healthy Community Design 
• National Environmental Policy Act 
involvement 
• None found  
YES for 
NIH  
10) Public health institutions should protect the 
confidentiality of information that can bring 
harm to an individual or community if made 
public.  Exceptions must be justified on the 
basis of the high likelihood of signif. harm to 
the individual or others 
• Health & Human Rights 
Workgroup 
• Office of Extramural 
Research: Research 
Involving Human 
Subjects 
 
 
NO 
11) Public health institutions should ensure the 
professional competence of their employees 
• PHEC on Education for staff 
• Education Strategic Plan 
• Annual ethics training 
for perm. employees  
 
NO 
12) Public health institutions & employees 
should engage in collaborations & affiliations 
in ways that build the public’s trust & 
institution’s effectiveness. 
• Agency pledge • Agency  goals 
• COPR 
• Public Trust Initiative 
 
NO 
a Principles of the Ethical Practice of Public Health, Public Health Leadership Institute, 2002. 
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Subfinding 1.2.a: CDC documents show that the agency has programs and activities that 
address most of the principles in the code of ethics 
The CDC’s mission, goals, and pledge address the code’s principles 1, 2, 5, and 12 and are 
supported and carried out by the agency’s component organizations.  The agency is undergoing a 
reorganization of its structure into 20 Centers, Institutes, and Offices that are tasked with 
carrying out the agency’s mission and goals which are stated as follows:   
“CDC Mission: Collaborating to create the expertise, information, and tools that people 
and communities need to protect their health – through health promotion, prevention of 
disease, injury and disability, and preparedness for new health threats.   
Goals: CDC seeks to accomplish its mission by working with partners throughout the 
nation and the world to monitor health, detect and investigate health problems, conduct 
research to enhance prevention, develop and advocate sound public health policies, 
implement prevention strategies, promote healthy behaviors, foster safe and healthful 
environments, and provide leadership and training” (Centers for Disease Control and 
Prevention).  
The agency’s mission, with a focus on prevention of disease, injury, and disability—adverse 
health outcomes—provides a clear link to the first principle.  In addition, by striving to deliver 
the knowledge and resources “communities need to protect their health,” the agency mission 
speaks directly to the idea of addressing the “requirements for health” as the first principle 
encourages.  One example of how the agency has implemented its mission is through the “CDC 
for You” segment of its website.  This element of the home page of CDC’s website includes 
links to pages designed to relay agency information and resources to a variety of publics 
including:  individuals in the general public, public health professionals, healthcare providers, 
students and educators, researchers, members of the media, policy makers, and businesses, thus 
addressing the agency’s mission “to create the expertise, information, and tools that people and 
communities need to protect their health” (Centers for Disease Control and Prevention). 
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One of the agency’s Centers in particular—the National Center for Chronic Disease 
Prevention and Health Promotion —has a mission that addresses principle 1 directly, in that it 
is tasked with “leading efforts that promote health and well-being through prevention and control 
of chronic diseases” (Centers for Disease Control and Prevention).  The Center’s five strategic 
priorities further support the intention of the first principle as well as principles 4 and 7: 
“1) Focus on Well-Being: Increase emphasis on promoting health and preventing risk 
factors, thereby reducing the onset of chronic health conditions.  
2) Health Equity: Leverage program and policy activities, build partner capacities, and 
establish tailored interventions to help eliminate health disparities.  
3) Research Translation: Accelerate the translation of scientific findings into community 
practice to protect the health of people where they live, work, learn, and play.  
4) Policy Promotion: Promote social, environmental, policy, and systems approaches that 
support healthy living for individuals, families, and communities.  
5) Workforce Development: Develop a skilled, diverse, and dynamic public health 
workforce and network of partners to promote health and prevent chronic disease at the 
national, state, and local levels” (Centers for Disease Control and Prevention). 
 The Center’s focus on well-being and reduction of chronic diseases further supports principle 
one, while the activities to ensure health equity address the fourth principle which encourages 
public health institutions to “work for the empowerment of disenfranchised community 
members.”  The code’s seventh principle suggests that “public health institutions should act in a 
timely manner on the information they have” —an idea which is supported by the Center’s 
strategic priority to “accelerate the translation of scientific findings into community practice.” 
 
The agency-wide goals that CDC has established for achieving its mission make explicit the 
agency’s responsibility not only to generate the knowledge and tools needed to assist 
communities, but also “to implement prevention strategies, promote healthy behaviors, foster 
safe and healthful environments, and provide leadership and training” which are tasks advised by 
the fifth principle.  In addition to the mission and goals, the agency pledges to the American 
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people, “to be a diligent steward of the funds entrusted to it; to provide an environment for 
intellectual and personal growth and integrity; to base all public health decisions on the highest 
quality scientific data, openly and objectively derived; to place the benefits to society above the 
benefits to the institution; and to treat all persons with dignity, honesty, and respect” (Centers for 
Disease Control and Prevention).  Its promise to be a “diligent steward” of the taxpayer funding 
it receives to carry out its work addresses a key element of principle twelve which encourages 
public health institutions to conduct its work “in ways that build the public’s trust.”  Finally, its 
pledge to “treat all persons with dignity, honesty, and respect” indicates the agency’s desire to 
engage with individuals in the communities it serves in the way that principle 2 encourages by 
achieving community health with “respect for the rights of individuals in the community.” 
The CDC’s Human Research Protection Office is another entity that addresses principle 2 in 
that its mission is to “lead the agency in protecting the rights and welfare of those who 
participate in CDC-sponsored public health research, through the practices of 
investigators, program leaders, and the CDC Institutional Review Boards (IRB), and 
through relationships with external partners” (Centers for Disease Control and Prevention). Any 
domestic or international research that is conducted by or funded by the agency must adhere to 
the Department of Health and Human Services’ Policy for Protection of Human Research 
Subjects, and most research involving human subjects must be approved by an IRB.  The Human 
Research Protection Office ensures that these policies are followed and facilitates the process of 
application to the IRB.  This component of CDC serves to protect the rights of individuals in the 
community who are participants in health research as advised by principle 2.   
There are two bodies within the agency that address the ideas espoused in principle 4 regarding 
advocacy and work for “the empowerment of disenfranchised community members” in order to 
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“ensure that the basic resources and conditions necessary for health are accessible to all” and in 
principle 8 which advises incorporating “a variety of approaches that anticipate and respect 
diverse values, beliefs, and cultures in the community.”  The first is the Office of Minority 
Health and Health Disparities which aims in part to “eliminate health disparities for vulnerable 
populations as defined by race/ethnicity, socio-economic status, geography, gender, age, 
disability status, risk status related to sex and gender, and among other populations identified to 
be at-risk for health disparities” (Centers for Disease Control and Prevention).  The office’s 
activities include promotion of minority health with the goal of eliminating racial and ethnic 
health disparities and development of agency-wide policies, strategies, and programs to address 
minority health.  The second body is the CDC/ATSDR Minority Initiatives Coordinating 
Committee which coordinates all the Department of Health and Human Services’ initiatives to 
address minority health within the agency.  In addition, the Committee “provides guidance and 
policy direction for minority health initiatives, serves as an advisor on matters related to minority 
health, and provides leadership in developing and implementing plans to improve minority 
health nationally” (Centers for Disease Control and Prevention). The committee includes 
representatives from each of the agency’s Centers.  
The sixth principle advises institutions to offer communities information “needed for decisions 
on policies or programs.” The CDC sponsors HealthComm Key, a program developed by 
Emory University that addresses this aspect of the principle.  The program is a searchable 
database that summarizes health communication studies that have been peer-reviewed and 
published (Centers for Disease Control and Prevention).  This resource could be used to help 
communities access information from previous studies and evaluations that can be helpful for 
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decision-making for public health programs by applying findings from the published studies 
included in the database.  
 
The ninth principle advises that “public health programs and policies should be implemented in a 
manner that most enhances the physical and social environment.”  The CDC addresses this 
principle with its Healthy Community Design web site which offers a variety of resources 
designed to assist communities in addressing the affects of the built environment on public 
health.  The resources include links to information on climate change, healthy community 
design, and health impact assessments to help communities determine a program’s impact on the 
environment (Centers for Disease Control and Prevention).  In addition, the agency has a role in 
carrying out the portion of the 1970 National Environmental Policy Act8 that requires federal 
agencies to consider the impact of its plans and programs on the environment.   The agencies 
must conduct an environmental impact assessment to review “the potential effect its initiatives 
might have on the nation’s social, economic, and natural resources” (Centers for Disease Control 
and Prevention).  Depending upon the results of this preliminary assessment, the agency may 
need to engage in a more detailed analysis and plan to address the impact of its programs.  The 
CDC participates in this environmental impact assessment process by reviewing and providing 
comments on submissions by other agencies—a responsibility the Department of Health and 
Human Services delegated to the agency.  
The CDC’s Health & Human Rights Workgroup helps to address principle 10 which 
encourages institutions to “protect the confidentiality of information that can bring harm to an 
individual or community if made public.”  In general terms, the Workgroup provides training to 
                                                           
8 42 U.S.C. §4321. 
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public health professionals “about health and human rights principles and the methods for 
incorporating these principles into public health practice” (CDC Public Health Ethics 
Committee, 2007) which addresses the tenth principle’s suggestion that public health institutions 
operate in a way that offers protection for those who participate in its research and programs. 
The Workgroup’s activities include “hosting seminars and workshops, co-sponsoring 
conferences, developing a compendium of resources, and collaborating with other groups on 
related issues” (CDC Public Health Ethics Committee, 2007).  
 While the agency has several programs and activities in place that address the education of its 
workforce—as principle 11 suggests—there is one coordinating body that serves as an example 
for coordination and planning workforce training in the area of public health ethics and “ensuring 
the professional competence of their employees.”  The Public Health Ethics Committee’s 
Education Subcommittee develops CDC capacity in public health ethics by coordinating the 
following activities: “assessing CDC resources, needs and competency relating to public health 
ethics; planning educational programs in public health ethics for CDC staff; conducting 
trainings, workshops, and seminars; evaluating public health ethics educational and training 
activities; and collaborating with other CDC groups on public health ethics- related educational 
activities” (CDC Public Health Ethics Committee, 2007).  The Subcommittee aims to increase 
public health ethics competency among its members and among agency staff by conducting a 
variety of trainings and activities in public health ethics, supporting research in this area, and 
evaluating the agency’s public health ethics activities.  In addition, the Subcommittee develops 
an Education Strategic Plan to plan and outline its activities in this area. 
Subfinding 1.2.b: NIH documents show that the agency has programs and activities that 
address most of the principles in the code of ethics 
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The NIH’s mission and goals directly address the public health code of ethics’ principles 1, 5, 
and 12 and are carried out by the agency’s 27 institutes and centers, each with its own mission, 
budget, and research agenda.  These organizational components conduct, coordinate, fund, or 
support health research for the agency and are tasked with carrying out its mission and goals 
which are as follows:  
“NIH’s mission is to seek fundamental knowledge about the nature and behavior of living 
systems and the application of that knowledge to enhance health, lengthen life, and 
reduce the burdens of illness and disability.   
The goals of the agency are: 
• to foster fundamental creative discoveries, innovative research strategies, and 
their applications as a basis for ultimately protecting and improving health;  
• to develop, maintain, and renew scientific human and physical resources that 
will ensure the Nation's capability to prevent disease;  
• to expand the knowledge base in medical and associated sciences in order to 
enhance the Nation's economic well-being and ensure a continued high return on 
the public investment in research; and  
• to exemplify and promote the highest level of scientific integrity, public 
accountability, and social responsibility in the conduct of science” (National 
Institutes of Health). 
The agency’s mission “to seek fundamental knowledge about the nature and behavior of living 
systems” directly addresses the code’s first principle which encourages institutions to address 
“… the fundamental causes of disease and requirements for health.”  In addition, the goals for 
the agency reinforce this principle as well as the fifth principle—to seek the information needed 
to implement effective policies and programs that protect and promote health—with their focus 
on the application of research for “protecting and improving health” and to “ensure the nation’s 
capacity to prevent disease.”  The agency goals to ensure a high return on financial investment 
and to promote scientific integrity and public accountability address the twelfth principle which 
states that institutions should conduct their activities in ways “that build the public’s trust and the 
institution’s effectiveness” by stressing the importance of fiscal responsibility and accountability 
to the taxpayers who fund the research carried out by the agency. In addition to the agency 
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mission and goals, NIH’s Office of Disease Prevention addresses the first principle in the code 
with its mission to “foster, coordinate, and assess prevention and health promotion research as 
part of the NIH effort to improve public health, reduce disease burden, and improve the quality 
of life for all Americans,” thus paralleling the code’s focus on “aiming to prevent adverse health 
outcomes” (National Institutes of Health). 
The Office of Extramural Research addresses the code’s second principle regarding respect for 
the rights of individuals in the community and its tenth principle regarding protection of 
confidentiality for individuals with its program for the protection of human research subjects.  
The program web site gathers in one place a number of resources for researchers engaged in 
work involving human subjects and provides links to training resources, regulations, agency 
policies, and special considerations for vulnerable populations.  For example, the site provides 
links to two training videos produced by NIH for the research community on current regulations 
for the protection of human research subjects and the use of their private information and how to 
report unexpected problems or adverse events when conducting research with human subjects.  
Researchers and others are welcomed to use and reproduce the videos as training resources in 
their own workplaces and research communities (National Institutes of Health). 
The NIH Director's Council of Public Representatives (COPR) is an advisory body whose 
activities address the code’s third, eighth, and twelfth principles.  The COPR is comprised of 
members of the public who provide feedback and advice to the Director of NIH on a range of 
issues including NIH research priorities, outreach, and other topics of interest to the public. It is 
the agency’s formal mechanism for obtaining public input into its activities.  Annually, the 
agency selects new members to serve on the COPR for an average of four years and aims to 
populate the COPR with members who represent diverse cultural, professional, and geographic 
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perspectives.  This program helps to ensure that the agency’s policies, programs, and priorities 
are developed with input from community members and that NIH incorporates input that 
respects “diverse values, beliefs, and cultures in the community” as the third and eighth 
principles encourage.  The COPR states that its goals include “serving as the public’s voice on 
issues relating to NIH’s mission, informing the public of the research and health benefits gained 
through the public’s investment in NIH, and helping NIH understand the public perspective and 
engage the public in NIH activities” (National Institutes of Health).  This serves as part of the 
agency’s means of engaging the public in its work, communicating its effectiveness to the public, 
and building trust among the communities it serves which is consistent with the twelfth principle. 
There are two components of NIH that address the forth principle in the code of ethics which 
encourages public health to “advocate and work for the empowerment of disenfranchised 
community members” and ensuring access to the conditions needed for health.  First, the Office 
of Research on Women's Health serves as a focal point for women's health research at the NIH.  
Under the purview of the NIH Director, the Office supports the agency’s role in improving 
women’s health by coordinating research on the effects of gender on health, partnering with the 
institutes and centers within NIH to ensure that research on women’s health is built into the 
research priorities across the agency, and provides advice to the NIH Director regarding 
women’s health research (National Institutes of Health).  Second, the National Institute on 
Minority Health and Health Disparities (NIMHD) addresses this principle as well as the 
eighth principle regarding respect for diverse values and cultures in the community through its 
vision and mission:  
“The NIMHD envisions an America in which all populations will have an equal 
opportunity to live long, healthy and productive lives. The mission of the National 
Institute on Minority Health and Health Disparities (NIMHD) is to promote minority 
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health and to lead, coordinate, support, and assess the NIH effort to reduce and ultimately 
eliminate health disparities” (National Institutes of Health). 
To fulfill its mission, the NIMHD conducts and supports research on, training about, and 
outreach to minority communities and others adversely affected by health disparities.  Like the 
Office of Women’s Health research, the NIMHD collaborates with the institutes and centers at 
NIH to ensure that the research agendas across the agency adequately address health disparities.  
In addition, the Institute works to ensure that the agency is engaging in dissemination of research 
results to the communities affected by health disparities.  
The NIH’s Policy on Enhancing Public Access to Archived Publications Resulting from 
NIH-Funded Research, which became effective in May 2005, addresses the sixth and seventh 
principles in the code which instruct public health institutions to provide information to 
communities for use in decision-making for policies and programs and to act in a timely manner 
on the information they have.  The public access policy was developed after a process of public 
hearings and comments solicited from the public, publishers, researchers, health care 
professionals, academics, and others with an interest in the accessibility of research results to the 
public.  The policy asks NIH-funded investigators to submit an electronic version of final 
research manuscripts to the NIH’s National Library of Medicine for inclusion in the searchable 
PubMed database which is a publicly available collection of research results.  The agency 
describes three main goals of the policy:   
“1) create a stable archive of peer-reviewed research publications resulting from NIH-
funded research to ensure the permanent preservation of these vital published research 
findings; 2) secure a searchable compendium of these peer-reviewed research 
publications that NIH and its awardees can use to manage more efficiently and to 
understand better their research portfolios, monitor scientific productivity, and ultimately, 
help set research priorities; and 3) make published results of NIH-funded research more 
readily accessible to the public, health care providers, educators, and scientists” (National 
Institutes of Health). 
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The policy pertains to authors whose research was funded completely or in part by NIH and asks 
that authors submit their work for inclusion in PubMed at the time a manuscript is accepted for 
publication, thus ensuring that results are available quickly to the public.  
The NIH’s ethics manual, “Without Integrity Nothing Works,” includes details regarding the 14 
ethical principles required of federal employees, a series of case studies/scenarios illustrating 
ethical dilemmas and resolutions, a list of key contacts for questions regarding ethics, and links 
to other ethics resources, policies, procedures, and documents (National Institutes of Health 
Ethics Office, 2009). One of the ways the agency ensures the competence of its employees, as 
encouraged in the eleventh principle in the code of ethics, is by the ethics training it requires of 
its employees and others engaged in the agency’s work.  These requirements are found in the 
ethics manual and include a mandatory ethics orientation for new employees, an annual training 
for all employees, and ethics training for non-employees including visiting fellows, agency 
volunteers, research trainees, and others who carry out the work of the agency but are not regular 
agency employees.   
Finally, the NIH’s Public Trust Initiative is another example of how the agency addresses the 
twelfth principle in the code of ethics, encouraging institutions to act in ways that build the 
public’s trust.  The Public Trust Initiative was established in 2004 by the Director of NIH with a 
mission “to enable the public to understand and to have full confidence in the research that NIH 
conducts and supports across the country and throughout the world” and the primary goal of 
having “the public recognize and trust the NIH in funding, conducting, and overseeing research 
to improve the health of the nation” (National Institutes of Health).  The program spans the NIH 
institutes and centers and provides a centralized catalog of activities and programs across the 
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agency that address public’s trust in the agency’s work.  Specifically, the Public Trust Initiative 
recognizes four key roles for the program: 1) to provide the public with information regarding 
NIH’s research, 2) to encourage the public to participate in setting the agency’s priorities, 3) 
making available opportunities for the public to participate in NIH research studies, and 4) 
providing the public with access to NIH-funded research results.  The program recognizes that 
there are many publics to which the agency is accountable and to whom its work is important 
including scientists, grantees, patients, advocacy groups, health care professionals, and the public 
at large.  To address these multiple publics, the program maintains a web site which displays the 
agency’s major public trust activities and categorizes them in ways that make it easy for a variety 
of audiences to access certain kinds of health and health research information including public 
education campaigns, Town Hall meetings, professional education, health fairs, school-based 
programs, programs for the general public such as lectures by NIH researchers on disease topics, 
clinical trials openly recruiting participants, research advocacy activities, opportunities for 
grantees, and programs and activities for the scientific community within and outside of NIH. 
Subfinding 1.1.c: The review of publicly available documents revealed some gaps between 
agency ethics programs and the public health code of ethics  
The review of publicly available documents revealed potential gaps for both agencies between 
current programs and three of the principles in the code of ethics. Regarding the advice in 
principle 3—to develop policies, programs, and priorities in a way that ensures input from 
community members—the search for CDC documents did not yield information about an 
agency-wide practice for addressing this.  While there were numerous references to the concepts 
of community input or community advisors for CDC programs or funded work, there was no 
information about how those concepts are operationalized.  Certain federal programs and policies 
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are announced and published in the Federal Register in advance of enactment in order for the 
general public to have an opportunity to comment on the proposed program.  While the CDC 
receives public input in this way, the document review yielded no central, agency-wide policy, 
position, or mechanism for soliciting or including input from targeted communities on the work 
of the agency. 
The public health code of ethics’ principle 6 encompasses two concepts for public health 
institutions and is partially addressed by both CDC and NIH.  The first concept—to provide 
communities with the information needed for decision-making—is addressed by both agencies as 
discussed in the previous two subfindings.  The second concept—to obtain the community’s 
consent for the implementation of policies or programs—was not explicitly addressed by either 
CDC or NIH based on documents reviewed for both agencies.  Finally, the code’s ninth 
principle—public health programs and policies should be implemented in a manner that most 
enhances the physical and social environment—was not addressed by NIH based on the 
documents reviewed for this study.  An analysis of these potential gaps is offered in the 
Discussions and Conclusions chapter. 
 
 
  
 
 
 
CHAPTER 5: DISCUSSION AND CONCLUSIONS 
 
The document review and key informant interviews were designed to provide insights into the 
study’s three key questions from different perspectives.  The objectives of the document review 
were to provide an agency-level overview of organizational components, programs, and policies 
that address the principles in the public health code of ethics, to illuminate any potential gaps 
between the code’s principles and the agency’s practices, and to determine targeted areas of 
questioning for key informant interviews with agency officials. The goal of the key informant 
interviews, in turn, was to develop a more detailed understanding of each agency’s organization, 
resources, and practices devoted to addressing the principles within the public health code of 
ethics and to tap into any information not readily available through a search of publicly available 
information.  This chapter contains a discussion of the findings from both study components – 
the document review and the key informant interviews—and are presented together by key 
research question. 
 
The three key research questions for this study, designed to determine whether there is a role for 
the public health code of ethics in the nation’s largest public health institutions, are as follows:  
• Key Question 1: In the context of the 12 principles of the public health code of ethics, 
what are the current practices of the CDC and the NIH, the two largest federal public 
health agencies?   
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• Key Question 2: To what extent has the public health code of ethics been given specific 
consideration by the two largest federal public health institutions?  
• Key Question 3: If benefits are identified, how can specific barriers to implementing the 
code of ethics be addressed to fill gaps in the agencies’ current ethics programs? 
 
Summary of Potential Gaps  
Taken together, the document review and the interviews with key informants revealed that there 
are two principles in the code of ethics for which gaps or potential gaps were identified for CDC 
and three for which gaps or potential gaps were identified for the NIH.  These are summarized 
Table 8 and are discussed in the narrative that follows. 
 
Table 8: Potential Gaps between Code of Ethics Principles and Agency Activity 
Principle from Code of Ethics (summarized) 
Not Fully Addressed by CDC and/or NIH  
Agency with 
Potential Gap 
Disposition 
#3: ensure an opportunity for input from community 
members 
CDC Discrepancy: addressed by 
interviews, but  not 
addressed by document 
review 
 
#5: implement effective policies and programs that 
protect and promote health 
NIH Discrepancy: addressed by 
document review, but not 
addressed by interviews   
 
#6: provide communities with information for decision-
making and obtain the community’s consent for 
program  implementation 
CDC  
and  
NIH 
Portion of principle 
(underlined) not addressed 
by document review or by 
interviews   
 
#9: enhance the physical and social environment 
 
NIH Not addressed by document 
review or interviews; falls 
outside of agency mission 
Note: “Potential Gap” indicates that no documentary evidence was found to fully address the principle and/or: 1) no interviewee 
offered examples of alignment with agency work or 2) at least one interviewee stated that the principle falls outside of the 
agency’s mission or the agency does not have policies or programs to address it.  
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Discussion of Results by Key Research Question 
Key Question 1: In the context of the twelve principles of the public health code of ethics, 
what are the current practices of the CDC and the NIH, the two largest federal public 
health agencies?   
Results from the document review and key informant interviews revealed that both agencies are 
addressing most of the principles in the code of ethics with their current practices, policies, and 
ethics activities.  In some cases, there were discrepancies between the findings from the 
document review and the interviews as summarized in the table above.  In general, these were 
not cases of conflicting information, but rather of information being offered or available from 
one collection method, but not the other.  For example, while a document may be available to 
describe a program addressing a given principle, interviewees from the agency may not have 
been aware of or failed to mention anything to address the principle.  In one case, only a portion 
of a principle was addressed by either agency.   
 
In the case of the CDC, this study revealed potential gaps between agency practices and two 
code of ethics principles.  First, for principle 3, while CDC officials widely agreed that the 
agency values and seeks input from the communities for which it designs programs, there was no 
publicly available evidence to support or describe how the agency does so.  This is noted as a 
potential gap because it may be that such a policy does exist but is not offered publicly, or that 
CDC staff routinely incorporate this practice into their work despite not having a policy to direct 
the activity.  Second, for principle 6, neither the document review nor the interviews provided 
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evidence that the CDC has any systematic way of obtaining “community consent” for programs 
it implements. 
The study revealed clear evidence that the remainder of the principles are addressed by CDC 
activities. In addition, agency officials noted that the language used in the code was directly 
related to the work of the CDC and is consistent with the agency’s mission.  In fact, the agency 
was instrumental in the code’s development, providing funding for the effort and having several 
officials involved in the development of the code.  In addition, several of the officials 
interviewed for this study regularly participate in the dissemination of the code to other agency 
staff and to audiences outside of the agency whom they may have occasion to address at 
meetings, conferences, and other venues.  This leads to the conclusion that the code is well-
designed for the agency and is consistent with the work of CDC. 
 
However, results from the study of the NIH, whose programs and policies address most of the 
principles in the code of ethics, indicated that although the spirit of the code of ethics is 
consistent with the agency’s mission, the way the code is written does not necessarily lend itself 
well to being accepted or adopted by NIH.  For example, the review of documents provided 
evidence that the fifth principle is addressed by the agency’s very mission—not only to seek 
knowledge, but to apply it to “enhance health, lengthen life, and reduce the burden of disease and 
disability” (National Institutes of Health).  However, key informants did not readily recognize 
the agency’s role in providing “information needed to implement effective policies and programs 
to protect health” as the fifth principle states.  One possible reason for this discrepancy is that the 
agency is not carrying out this portion of its mission and instead, is solely focused on generating 
new knowledge rather than applying it.  However, given the documentary evidence of numerous 
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programs and public health campaigns run by the agency using its research results as an 
evidence-base, the more likely reason for the discrepancy between the results from the document 
review and key informant interviews is that in general, those in leadership positions related to 
ethics at the agency are engaged in the establishment and enforcement of biomedical research 
ethics programs and the standards for ethical conduct for government employees rather than for 
public health programs.  This notion was reinforced by one NIH official who characterized the 
agency’s role as research-focused and not implementation-focused 
Similarly, neither the document review nor the key informant interviews revealed evidence of the 
agency addressing the ninth principle—“Public health programs and policies should be 
implemented in a manner that most enhances the physical and social environment.”  While NIH-
funded research may be applied by others to address this principle, the implementation of 
programs and policies to enhance the environment does not seem to fit directly with the agency’s 
mission.  Therefore, it is reasonable that this principle might not be addressed by the agency.  
Finally, as was the case with the CDC, this study did not reveal evidence that the NIH 
systematically of obtains “community consent” for programs it implements.  This could be an 
indication that the agency does not do this or it could mean that the practice is not documented in 
a policy or if it is, the policy may not be publicly available.  Another possibility is that the 
concept of community consent needs clarification from the authors of the code in order to be 
understood and operationalized.  In any case, it is noted here as a potential gap between the 
agency’s practice and the code of ethics principle 6. 
 
Key Question 2: To what extent has the public health code of ethics been given specific 
consideration by the two largest federal public health institutions?  
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The results of this study showed that the key informants from the CDC had a high degree of 
familiarity with the code, that the agency provided support for its development in the form of 
funding and staff involvement, and that it is an integral part of the agency’s public health ethics 
program.  For example, it is the framework around which the agency’s key public health ethics 
document is built (CDC Public Health Ethics Committee, 2007).  The agency uses the code as a 
tool to help articulate its own policies and practices for public health ethics and uses it in its 
ethics education for staff.  In this way, the code is already integrated into the agency’s programs 
and is widely accepted as a set of principles that fits well with the CDC’s mission and work. 
Given this high degree of familiarity, use, and alignment with mission, the agency has 
considered adopting the code, but ultimately declined to do so.  The decision not to adopt the 
code appears to be less of a deliberate choice against doing so, and instead reflects a shift in 
agency priorities to other pressing matters.  Since the deliberations about adopting the code took 
place, there has been a change in administration of the agency and with it a new set of priorities.  
As CDC officials described the situation, the matter of formally adopting the code—or 
continuing the discussion about doing so—simply hasn’t risen to the top of the priority list.  That 
the code is in use and is as integrated into the agency’s programs as it is indicates its success as a 
document that can be accepted and operationalized into a large public health institution.  One 
might assume that if the code could be accepted and infused into the programs of a large federal 
agency, it could also be accepted into smaller bureaucracies at the state and local levels assuming 
the code aligns as well with the missions of those organizations as it does with CDC’s mission.   
 
In fact, interviewees from the Public Health Leadership Society who were familiar with the 
code’s development and dissemination noted that local and state public health agencies are a key 
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audience to whom they are speaking about the code of ethics and how it can be used to assist 
public health professionals working through ethical dilemmas and to design and manage public 
health programs in an ethical way.  One of their goals is to introduce the code to a wider circle of 
public health professionals through speaking engagements and workshops across the country.  
The Public Health Leadership Society’s dissemination goals are made challenging due to a lack 
of funding.  While there was funding available—from CDC and others—to develop the code, 
funding has not been available to take the next steps to publicize, disseminate, and track the 
code’s use.  Finally, the findings for this study showed no familiarity with the code among NIH 
officials interviewed for this study and therefore, there has been no consideration of adopting the 
code for the agency.   
 
Key Question 3: If benefits are identified, how can specific barriers to implementing the 
code of ethics be addressed to fill gaps in the agencies’ current ethics programs? 
In the case of the CDC, officials noted that unresolved questions about the agency’s authority 
and enforcement of the code pose a barrier to adopting it.  In particular, the leadership group that 
deliberated on the issue of adopting the code struggled to clarify what the agency’s legal 
responsibility would be to enforce the code if it was adopted.  This circumstance reveals a 
dilemma for a code that is aimed at organizations rather than individuals.  In its articulation of 
the rationale for the code of ethics, the Public Health Leadership Society states that “A code of 
ethics thus serves as a goal to guide public health institutions and practitioners and as a standard 
to which they can be held accountable” (Public Health Leadership Society, 2002).  Currently, the 
CDC is using the code as a part of its guidance on public health ethics by its integration into the 
agency’s public health ethics program and education.  If the code is meant to serve as a standard 
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to which organizations are held accountable as the PHLS statement suggests, this question of 
agency authority for enforcement remains an issue to be debated and resolved prior to acceptance 
of the code formally.   
In the course of the research for his study, it became clear that while the CDC makes a 
distinction between research ethics and public health ethics, the NIH does not.  This led to 
difficulty among key informants from NIH trying to translate research ethics activities into 
responses to questions regarding public health ethics.  Because the vast majority of NIH’s work 
and budget are devoted to research rather than public health programs, this seems to be a 
reasonable approach to the design of the agency’s ethics programs.  In addition, NIH officials 
saw general alignment of the code’s principles with the agency’s mission; however, they 
questioned what value the code would bring to an agency whose resources are focused mainly on 
biomedical research. Finally, as with the CDC officials, NIH interviewees expressed concern 
regarding the agency’s legal authority to establish and enforce a new set of standards for its 
workforce.  In conclusion, the interviewees’ concerns regarding the focus of the code’s 
principles, the questionable value of the code for the agency, and questions about authority to 
enforce the code pose barriers that make adoption of the code at the NIH both infeasible and 
unnecessary. 
Conclusions and Recommendations 
The fact that both agencies are already addressing most of the principles within the code begs the 
question of what, if any, value the formal adoption of the code might have.  Based on alignment 
with agency mission, knowledge of the code among ethics leaders, feasibility of adoption of the 
code, and potential value added to the agency and the field of public health, the study results lead 
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to the following recommendations for the CDC, NIH, and the Public Health Leadership Society, 
the body responsible for the creation of the code: 
 
The CDC should formally adopt the public health code of ethics. 
The study shows that the principles in the code of ethics align well with the with agency’s 
mission and that the ethics leaders who participated in this study all had extensive knowledge of 
the code and, in fact, use it in the course of their work.  In addition, adoption of the code is 
feasible for the CDC because the agency recognizes a need for a distinct public health ethics 
program to address the work it does and the code is already integrated into the ethics program.  
Finally, although there may be limited value or change to the agency by adopting the code, the 
value added would be largely external.  The benefit to CDC adopting the code would be mainly 
to the field of public health.  Adopting the code of ethics in a formal way would give prominence 
to the code and would position the CDC as a model for state and local public health institutions 
nationwide that may be considering adopting it.    
 
The NIH should consider using the public health code of ethics within the workgroups that 
manage public health campaigns and programs. 
The findings of this study indicate that NIH adopting the code has questionable value and low 
feasibility.  The ethics leaders who participated in the study were not familiar with the code and 
while they found the principles generally consistent with the agency’s work and mission, 
questioned what value adopting it would add agency-wide.  The agency-wide ethics program is 
appropriately focused on the majority of the work there—basic biological research.  However, 
there may be some value to introducing the code to the segment of the NIH workforce 
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responsible for implementing public health programs and campaigns. Using the code as a tool in 
the design and management of public health programs could assist in disseminating it to a wider 
group of public health professionals and could enhance that specific segment of the agency’s 
work.   
 
The Public Health Leadership Society should more clearly articulate the need the code 
addresses and track its use to help build an evidence base for its adoption 
The study revealed that there was low recognition of the code among NIH officials whose 
expertise is in the field of ethics.  Interviewees involved in or familiar with the development and 
dissemination of the code indicated that they were not aware of any organized or systematic 
collection of information about how the code is being used or which organizations or institutions 
have adopted it.  If the goal is to have the code disseminated and put into use widely among 
public health institutions, the Public Health Leadership Society should develop a strategy for 
tracking and reporting on the use of the code so that others may benefit from the lessons of those 
who have successfully done so.  This, in combination with encouraging a robust body of 
published work in which the code is studied, featured, and explored for benefits to the public’s 
health would increase the code’s visibility in the field and enhance the chances of it being 
formally adopted by organizations who could use data about the code’s use to help justify 
formalizing it in their own organizations. 
Limitations of this Research  
Limitations of this research include factors that are common to the methods used to collect 
information for this study—document review and key informant interviews.  In addition, there 
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are limitations unique to the topic and design of this study.  As the methods chapter discusses, 
this study began with an initial round of document review, progressed to key informant 
interviews, and included a second round of review of documents suggested or provided by 
interviewees.  The initial document review was limited to what was available publicly through 
each agency’s web sites and other venues.  While this study drew conclusions from that 
information about the scope of each agency’s ethics programs, there are limits to how 
comprehensive of a picture can be drawn based on this source.  For example, just because an 
agency has a policy or program and makes documentation about it available, it does not mean the 
particular code of ethics principle it addresses receives the attention it may warrant.  In addition, 
most of the publicly available documents give no indication of how rigorously a particular 
program is enacted or enforced.  Finally, there may be other policies or programs in place that 
did not appear in a search of publicly available information.  These limitations were mitigated by 
following the document review with key informant interviews and a second phase of document 
review which provided an opportunity to clarify and probe on the initial document review 
findings and to triangulate the evidence.  
The key informant interviews were subject to bias both in terms of selection and responses.  
First, the interview sample size is relatively small given the size of the two agencies studied.  
Key informants, although high level and very knowledgeable, may not be aware of all policies 
and programs across the entire agency.  Key informants with knowledge of the development and 
dissemination of the code had limited knowledge about the status of any formal efforts on the 
part of the Public Health Leadership Society to disseminate the code and track the organizations 
which have adopted it.  Because some representatives from the Public Health Leadership Society 
declined or did not respond to a request to be interviewed for this study, a gap exists in the full 
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picture of how the organization is disseminating the code and what its plans are for revising it or 
evaluating its use.   
Efforts to address these limitations and potential biases included corroborating information 
gathered from the interviews with documentary evidence, including key informants from CDC 
and NIH who have expertise in the area of ethics within particular divisions of each agency as 
well as those who have an agency-wide perspective of ethics programs.  Finally, the study has 
the potential for bias in responses due to the interviewees’ role in the programs discussed and the 
researcher’s role as an analyst at the GAO, the agency charged with auditing Executive Branch 
agencies including the CDC and NIH.  This affiliation was disclosed to all invited interviewees 
at the initial contact which may have affected who was willing to participate in the study as well 
as responses provided by those who did participate.  
  
 
 
 
CHAPTER 6: PLAN FOR CHANGE 
 
The public health code of ethics is a tool that is aligned with the CDC’s mission and is well-
suited for formal adoption by the agency which, while perhaps not creating a great change in the 
agency’s public health ethics practices, would serve as a model and a signal that the agency has 
espoused the principles and is maintaining public trust by committing to a clear set of principles 
by which it conducts its work on behalf of the public.  The NIH has an ethics program that is 
appropriately geared toward research ethics and would not benefit from adopting the public 
health code of ethics nor would such a suggestion be feasible.  However, the NIH may find some 
use for the public health code of ethics among the segment of the workforce that designs, 
manages and evaluates public health education, campaigns, and programs.  In addition, the 
Public Health Leadership Society could use some of the information gained from the results of 
this study to clarify and extend the reach of the public health code of ethics. 
Recommendation 1: The CDC should formally adopt the public health code of ethics. 
The CDC Public Health Ethics Committee has publicly stated that “a systematic, deliberate 
ethical analysis” would provide an added value to the CDC’s decision-making process given that 
the ethics problems it addresses are often complex, involve several risk factors, and involve 
multiple stakeholders with varied perspectives and values (CDC Public Health Ethics 
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Committee, 2007).  Further, the Committee recognizes two main rationales for instituting a 
systematic approach to ethical decision-making at the CDC: “1) to make sound decisions which 
are most in agreement with public health and other societal values, and 2) to help ensure that the 
decisions we make are supported by those who are affected by our actions” (CDC Public Health 
Ethics Committee, 2007).  The Committee refers to the public health code of ethics as a 
document which articulates the key values of the field and, in fact, provided funding for the 
code’s development by the Public Health Leadership Society.  The timing is right for the agency 
to formally adopt the public health code of ethics.  The CDC Public Health Ethics Committee 
has recommended a more formal structure for its ethical decision-making processes, has 
recognized the code as the articulation of the values of the field, and is actively working to 
strengthen the agency’s role in public health leadership (July/August 2008).  This change is 
feasible and important to the agency, the local and state public health institutions it funds, and to 
field of public health.  Following are suggested steps to achieve this change: 
Build a Workgroup:  The CDC officials interviewed for this study noted that the initial 
discussions about adopting the code were rather informal and included a variety of leaders within 
the agency.  Since that time, the agency has undergone a re-organization and has new leadership 
at the top.   A gathering of the decision-makers and key advisors to the CDC Administrator into a 
workgroup to study the feasibility of adopting the code would provide an organized approach to 
studying the issue and arriving at recommendations for the CDC Administrator. In order to 
appeal to the agency administration with a compelling rationale and plan for adopting the code, 
leaders within the agency should engage the appropriate stakeholders in the process from the 
beginning to ensure widespread support (Kotter, 1996)and ensure that the team is led by 
efficient, knowledgeable and passionate people (Harari, 2002).  
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Create a vision for change and communicate it to staff and other stakeholders:  Be clear 
about the plan for action, the steps necessary for success, and keeping staff and other 
stakeholders apprised (Harari, 2002; Kotter, 1996).  The deliberations as well as the process for 
adopting the code should be transparent to staff and the public.  One of the benefits of having the 
CDC adopt the code is external—so that it can serve as a model agency for other public health 
institutions.  An open debate of the barriers and benefits to adopting the code will serve those 
who may be considering doing the same.  The CDC has worked hard to position itself as a 
federal leader in the area of public health ethics and formal adoption of the code is an important 
an opportunity to solidify its role as a leader in this realm.   
Be clear and concise and keep the goal in mind:  Both in terms of communicating workgroup 
recommendations to the decision-maker(s) in order to have the code adopted and then 
communicating the change to CDC personnel, talking and teaching points must be clear, concise 
and logical so that the reason for supporting adoption of the code is obvious (Harari, 2002).  
Taking the message a step further (and outside of the agency), communicating the CDC decision 
to adopt the code in clear, concise, and consistent language will help in the effort to disseminate 
the  code further into the field.  While it is important to monitor the details involved with 
working through the barriers to adopting the code of ethics, it is equally crucial to keep the whole 
picture in mind so that the goal of systemic change is not lost (Gerzon, 2006).  A proposal to 
adopt the code may take time to be vetted and accepted, but each workgroup meeting, 
presentation, and training on the code of ethics increases awareness and promotes interest and 
discussion on the issue within the agency.  These are key activities in the movement to influence 
decision-makers and change culture on multiple levels (Gerzon, 2006; Kotter, 1996).  
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Recommendation #2: The NIH should consider using the public health code of ethics within 
the workgroups that manage public health campaigns and programs. 
While the NIH’s ethics program is appropriately focused on its primary mission—to conduct 
basic biologic research—the public health code of ethics may be of value to the segment of the 
NIH workforce that designs and implements public education materials and campaigns, namely, 
the communications offices throughout the agency as well as those who conduct community-
based research programs.  The communications offices in each institute are typically the 
locations from which public health campaigns and educational programs are designed, managed, 
and evaluated.  If the NIH’s Office of Communications and Public Liaison—the central 
coordinating body for communications activities across the agency—were to espouse the 
principles in the code for public health programs, it could become a useful tool for the numerous 
communications offices throughout the NIH.  In addition, the NIH conducts several large 
research studies that are based in communities and are reliant upon strong community 
connections such as the National Children’s Study and the Framingham Heart Study.   
 
The code of ethics may offer important guidance to the researchers who are involved in creating 
community partnerships, designing the studies, recruiting participants, and implementing the 
research with these populations.  Because these researchers and the communications offices deal 
directly with implementing programs and sharing information that could be valuable to 
communities making decisions about policies and programs, the code could provide a helpful 
framework from which to operate the ethical design and implementation of programs and 
partnerships.  Given that the code’s principles are generally aligned with the agency’s mission, 
applying the code with a subset of the agency workforce could be a feasible approach to 
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integrating the principles into the work of these offices, without the need for the agency to 
formally adopt the code which this study showed to be infeasible and unnecessary.   
 
The ideal strategy for disseminating the code to these sectors of the NIH workforce is a 
centralized approach to accepting and sharing the principles.  This could be accomplished by 
presenting the code, with some context for why it would benefit the agency, to the NIH Director 
for consideration.  The rationale could include the benefit to the agency of recognizing the 
principles as important for NIH’s work within communities in a proactive way—before there is a 
need to justify or defend agency programs.  If the Director accepts that the code is appropriate 
guidance for health communication and research programs, it could be shared through his regular 
meetings with institute and center Directors for dissemination throughout the agency.  This 
encouragement from top leadership would serve to bring greater awareness of the code which 
this research showed was lacking among NIH ethics officials and could offer a set of principles 
focused on public health work to the segment of the agency’s workforce most directly involved 
with research and education for communities.  The code’s principles could be included in 
recruitment materials to show potential study participants that in addition to the NIH’s rigorous 
research ethics and protections for human subjects, the agency is sensitive to and concerned 
about designing and conducting research in ways that are respectful of the communities the 
research is designed to serve.   
 
A second approach to sharing the code among the agency employees working directly with 
communities is to present it to the NIH’s Office of Communications and Public Liaison—the 
agency’s central coordinating body for all institute and center communications offices.  Similarly 
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to the first approach, providing a rationale to the leader of that office would encourage 
acceptance of the code as a tool that could offer important guidance to the agency’s 
communications and public health workforce.  While this strategy may be somewhat easier than 
accessing the NIH Director, it is somewhat less effective because the reach it would provide to 
the NIH workforce is not as wide, potentially missing the researchers designing and conducting 
community-based research since that work is not typically coordinated through the 
communications offices.  In addition, the effect of having the leader of one division—the Office 
of Communications and Public Liaison—encourage the code’s use is less compelling than if the 
message came from the agency’s top leadership. 
 
Finally, another way the code could be operationalized informally within the agency is through 
the code’s inclusion in an important publication on managing health communications programs.  
The National Cancer Institute—a component of the NIH— publishes a program manual entitled 
“Making Health Communication Programs Work” (National Cancer Institute, 2002).  The 
manual includes guidance relevant to several of the code of ethics’ principles.  The code could be 
included and infused into the fabric of the manual and in the process, could inspire more staff in 
the agency (and many outside the agency who use the guide) to aspire to the principles and to 
increase familiarity with the code in an important public health institution. 
 
Recommendation #3: The Public Health Leadership Society should expand upon its 
rationale for the code of ethics and build an evidence base for its adoption. 
In its 2002 publication of the public health code of ethics, the Public Health Leadership Society 
provided supporting materials including an explanation of the values and beliefs that underlie the 
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code, a crosswalk between the code’s principles and the essential public health services, and a 
brief “Rationale for a Public Health Code of Ethics” (Public Health Leadership Society, 2002).  
The rationale describes two purposes for the code—as guidance for public health organizations 
and practitioners and as a set of standards to which they can be held accountable.  These are two 
very different uses for the code with differing levels of complexity for an institution considering 
adopting the code as the case of the CDC illustrates.  The agency currently uses the code to 
provide a framework for its public health ethics program and encourages its use to guide staff in 
how to conduct public health programs in an ethical way, thus addressing the first part of the 
PHLS rationale for the code (CDC Public Health Ethics Committee, 2007).  This is a relatively 
simple way for an organization to use the code.  More complex is establishing it as a standard 
against which the institution and staff are measured.  In the case of the CDC—and one could 
imagine other organizations as well—using the code in this way requires a different level of 
commitment and resources and therefore requires a more rigorous approach to justifying the 
adoption of the code. 
A unique feature of the code is its focus on institutions rather than individual practitioners of 
public health.  This feature presents a challenge to those who are working to disseminate it and 
those who wish to adopt it.  The Public Health Leadership Society can play a key role in 
addressing this challenge by providing a more rigorous rationale for the code.  This includes 
enhancing its original rationale with information on how the code is being used and adopted in 
the field and sharing best practices for doing so.  Steps to building a more robust rationale for the 
code include: 
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Track the use and adoption of the code 
The Public Health Leadership Society could undertake a study of familiarity and use of the code 
among public health institutions such as state and local public health departments and other key 
audiences for the code.  This could be modeled on the CDC’s Public Health Ethics Survey 
fielded among agency staff at the time this dissertation research was in process.  Such a study 
could provide a valuable snapshot of where the code is being used and under used according to 
the Society’s goals.  Next, the Society could use the study results to develop a strategy for 
outreach and dissemination, targeting the organizations it believes could benefit from but are not 
using the code.  In addition, by publicizing the results of such a study, the organization would be 
providing valuable information to groups who may use the data to support use of the code in 
their organizations. 
Share best practices for using and adopting the code 
While the original publication of the code calls it a “living document,” the Society does not offer 
a clear and active route for feedback or additional information about how the document may be 
revised or updated.9  Offering a clear and public forum for feedback and stories about how the 
code is operationalized in some organizations could be of benefit to others seeking evidence to 
justify its adoption.  Establishing a blog or some other repository for stories from the field could 
help to provide valuable lessons about how groups have handled the dilemma of whether to 
enforce the principles or use them as guidance rather than for accountability.   
 
                                                           
9 The PHLS rationale for the code sends readers to its web site to provide feedback on the code.  At the time this 
study was undertaken, there was no active link or explanation about how to submit feedback or to whom. 
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Encourage the publication of a greater body of work on the impact of this and other codes 
of ethics on programs or outcomes.   
While not strictly in the purview of the Public Health Leadership Society, the organization could 
play a role in encouraging public health professionals to build an evidence base for adoption 
(formal or informal) of the public health code of ethics.  Many articles have used the code to 
discuss specific case studies and public health scenarios such as flu vaccines, pandemic influenza 
planning, genomics, and others (Melnick et al., 2005; Thomas, Irwin, Zuiker, & Millikan, 2005a; 
Thomas, Irwin, Zuiker, & Millikan, 2005b; Thomas et al., 2007).  However, as the literature 
review for this study found, there is a gap in the literature on the code’s adoption and use in 
programs.  Tracking and reporting along with published peer reviewed articles would help build 
a base for strengthening the rationale for others to adopt the code.  The Public Health Leadership 
Society has made an important contribution to the field in its creation of the public health code of 
ethics.  It could increase the code’s use and utility to the practice of public health by taking the 
next step to enhance the rationale for its adoption which could in turn facilitate greater number of 
organizations in their efforts to adopt the code formally. 
In conclusion, there is a role for the public health code of ethics in the federal workforce.  The 
CDC should adopt the code for use agency-wide and the NIH should consider using the code 
with the segment of its employees doing direct public health outreach.  The Public Health 
Leadership Society should take a more active role in articulating the need for the code and 
engage in activities that will facilitate a wider use of the code. 
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Appendix A 
 
Fact Sheet for Adult Participants in a Research Study 
University of North Carolina-Chapel Hill 
________________________________________________________________________ 
IRB Study #09-1834 
Consent Form Version Date:  May 2009 
Title of Study: Applying the Public Health Code of Ethics to the Federal Workforce 
Principal Investigator: Jill K. Center, MPH 
UNC-Chapel Hill Department: School of Public Health, Department of Health Policy and 
Management 
UNC-Chapel Hill Phone number: 919/966-7364 
Faculty Advisor:  Edward Brooks, DrPH, MBA 
Study Contact telephone number:  202/544-8112 
Study Contact email:  jcenter@email.unc.edu 
_________________________________________________________________ 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary.  
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, 
without penalty.  
Research studies are designed to obtain new knowledge. This new information may help people 
in the future.   You may not receive any direct benefit from being in the research study. There 
also may be risks to being in research studies. 
Details about this study are discussed below.  It is important that you understand this information 
so that you can make an informed choice about being in this research study.   
You will be given a copy of this consent form.  You should ask the researchers named above, or 
staff members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study?  
The purpose of this research study is to learn about how the public health code of ethics relates to 
the ethics programs already in place at The National Institutes of Health and the Centers for 
Disease Control and Prevention.   
You are being asked to be in the study because you have professional responsibilities related to 
training, implementation, or oversight of ethics programs, policies, and procedures within your 
agency or office. 
 
How many people will be interviewed for this study? 
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If you decide to be interviewed for this study, you will be one of approximately 15-20 people 
interviewed for this research study. 
 
How long will your part in this study last?  
If you decide to be interviewed for this study, you will be asked to meet in-person or by 
telephone for a 45-60 minute interview.  If you agree, you may also be contacted by e-mail or 
telephone to address follow up questions or clarifications if needed. 
 
What will happen if you take part in the study? 
Participation in interviews for this study will involve the following steps: 
• Read this fact sheet and the information enclosed to determine your interest in participating 
in this study 
• Contact the researcher listed on the first page of this form with any questions or concerns 
regarding your participation 
• Schedule a time to participate in a 45-60 minute interview (interviews may be conducted in-
person or over the telephone) 
• Read the enclosed 12 page code of ethics entitled Principles of the Ethical Practice of Public 
Health before the interview and consider whether or how it aligns with your 
agency’s/organization’s mission 
• Participate in a 45-60 minute interview in-person or over the telephone 
• Address follow up questions or clarifications if needed after the interview 
 
What are the possible benefits from being in this study? 
You may benefit from participation in this study by discovering ways the public health code of 
ethics could enhance the current ethics programs and policies in place in the agency where you 
work. This research is designed to benefit society by gaining new knowledge.  You may not 
benefit personally from being in this research study. 
 
What are the possible risks or discomforts involved from being in this study? 
There are no known or expected risks to participating in this study.  
 
How will your privacy be protected? 
The researcher listed on the first page of this form is the only person who will have access to 
information that links individual participants to the responses from their interviews.  
• Participants will be asked for permission before being identified in any report or publication 
about this study.   
• Records of the interview will be stored electronically in password protected files.  
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• At the time of the interview, participants will be asked for permission to record the interview 
for transcription. If an interview is recorded, a transcript will be made and the audiotape will 
be destroyed.   
• Any hardcopy information linked to an individual’s responses to interview questions will be 
stored in a locked file cabinet.  
 
Although every effort will be made to keep research records private, there may be times when 
federal or state law requires the disclosure of such records, including personal information.  This 
is very unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by 
law to protect the privacy of personal information.  In some cases, your information in this 
research study could be reviewed by representatives of the University, research sponsors, or 
government agencies for purposes such as quality control or safety. 
 
Will you receive anything for being in this study? 
You will not receive anything for taking part in this study. 
 
Will it cost you anything to be in this study? 
Other than your time, there will be no costs for participating in the study. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If 
you have questions, or concerns, you should contact the researcher listed on the first page of this 
form. 
What if you have questions about your rights as a research participant? 
All research with human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research participant you 
may contact, anonymously if you wish, the Institutional Review Board at 919/966-3113 or by 
email to IRB_subjects@unc.edu. 
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Appendix B 
Key Informant Interview Tool A: Question Set for Officials at the National 
Institutes of Health and the Centers for Disease Control and Prevention 
 
Welcome 
Thank you for agreeing to participate in this interview to discuss the public health code of ethics.  
I am Jill Center, a student in the UNC Doctor of Public Health Program.  I am also a Health 
Policy Analyst at the U.S. Government Accountability Office.  As I indicated in the introductory 
letter, the information I collect as a part of this study is for my dissertation research and is not 
related to any active GAO engagement.10 I will not share any details from this interview with 
colleagues at GAO.  I may publish portions of the dissertation, in which case the findings would 
become publicly available.  
In order to fully capture your responses today, I would like to record our conversation.  Do I 
have your permission to do so?  [If yes]: If you would like to have me stop the recording at any 
point in our conversation, please let me know and I will stop the recording. 
 
Introduction 
Leaders in public health have undertaken an effort to further “professionalize” the field by 
identifying a common set of competencies for the public health workforce, marketing a national 
credentialing examination to test for mastery of several core competencies, and proposing that 
public health professionals be certified to engage in certain core activities.  Another aspect of this 
movement is the development of a code of ethics for public health institutions. 
In 2002, the Public Health Leadership Society published the Principles of the Ethical Practice of 
Public Health (code of ethics), which includes the twelve principles that make up the code of 
ethics.  Although it was adopted by the American Public Health Association and has been 
endorsed by several public health organizations, there appears to be little organized effort to 
disseminate the code or to integrate it into the public health workforce.  
In order to learn about whether the code of ethics would be a useful tool for the two largest 
public health agencies—NIH and CDC— I am conducting a series of interviews with ethics 
professionals and other officials at the two agencies.  Thank you for agreeing to participate in 
this interview to discuss your opinions about the public health code of ethics and to share 
                                                           
10 Key informants received an introductory letter describing the research objectives, my affiliation with GAO, and a 
copy of the public health code of ethics.  The letter requested that participants read the code of ethics in advance of 
the interview. 
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information about your agency and how the code of ethics might fit into its ethics program. 
 
Interview Questions 
1. Please describe your role in the agency’s ethics program.  
 
2. Had you seen or heard about the public health code of ethics before I sent it to you? 
 
3. To what extent does the public health code of ethics align with your agency’s mission?  
 
4. For the elements you identified that align with the agency’s mission, to what extent do 
current agency policies and practice address these? [If participant does not mention 
gaps revealed by my analysis of publicly available documents, probe on those items.] 
 
5. How does your agency train employees in the ethics policies and what support is 
available when an ethical question arises? 
a. How does your agency keep them informed of changes to the policies? 
b. Are there documents you could share pertaining to these practices? 
 
6. What is the process for making a change to your agency’s ethics programs?  
a. Who are the decision-makers? 
b. Are there documents you could share pertaining to these procedures? 
 
7. Please describe any barriers to changing your agency’s ethics programs. 
 
8. If you identified an element of the code of ethics that you thought should be adopted by 
the agency, what would be the steps you would need to take to have the idea 
considered?  
 
9.   [If applicable]: Of the elements we’ve discussed that align with your agency but are not 
currently reflected in its policies, which do you think are the most important?  
 
10.   Are there any additional thoughts or opinions about the public health code of ethics that you 
would like to share?  
 
11. Are there others at NIH/CDC that you would recommend I speak with about this topic? May 
I contact you again with follow up questions or for clarifications? 
 
Conclusion 
Thank you for your time today to discuss the public health code of ethics.  The information and 
insights you shared will be valuable to my study. May I use your name and title in the final 
report, or would you prefer that I keep all or part of that information anonymous?   If you are 
interested, I would be happy to share the results of my research when the final report has been 
approved and accepted by UNC (expected 2010). 
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